1
|
Olivares-Vicente M, Sánchez-Marzo N, Herranz-López M, Micol V. Analysis of Lemon Verbena Polyphenol Metabolome and Its Correlation with Oxidative Stress under Glucotoxic Conditions in Adipocyte. JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY 2024; 72:9768-9781. [PMID: 38629896 PMCID: PMC11066870 DOI: 10.1021/acs.jafc.3c06309] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 11/17/2023] [Revised: 03/21/2024] [Accepted: 03/26/2024] [Indexed: 05/02/2024]
Abstract
Lemon verbena has been shown to ameliorate obesity-related oxidative stress, but the intracellular final effectors underlying its antioxidant activity are still unknown. The purpose of this study was to correlate the antioxidant capacity of plasma metabolites of lemon verbena (verbascoside, isoverbascoside, hydroxytyrosol, caffeic acid, ferulic acid, homoprotocatechuic acid, and luteolin-7-diglucuronide) with their uptake and intracellular metabolism in hypertrophic adipocytes under glucotoxic conditions. To this end, intracellular ROS levels were measured, and the intracellular metabolites were identified and quantified by high-performance liquid chromatography with a diode array detector coupled to mass spectrometry (HPLC-DAD-MS). The results showed that the plasma metabolites of lemon verbena are absorbed by adipocytes and metabolized through phase II reactions and that the intracellular appearance of these metabolites correlates with the decrease in the level of glucotoxicity-induced oxidative stress. It is postulated that the biotransformation and accumulation of these metabolites in adipocytes contribute to the long-term antioxidant activity of the extract.
Collapse
Affiliation(s)
- Mariló Olivares-Vicente
- Instituto
de Investigación, Desarrollo e Innovación en Biotecnología
Sanitaria de Elche, Universidad Miguel Hernández
(UMH), Elche 03202, Spain
| | - Noelia Sánchez-Marzo
- Instituto
de Investigación, Desarrollo e Innovación en Biotecnología
Sanitaria de Elche, Universidad Miguel Hernández
(UMH), Elche 03202, Spain
| | - María Herranz-López
- Instituto
de Investigación, Desarrollo e Innovación en Biotecnología
Sanitaria de Elche, Universidad Miguel Hernández
(UMH), Elche 03202, Spain
| | - Vicente Micol
- Instituto
de Investigación, Desarrollo e Innovación en Biotecnología
Sanitaria de Elche, Universidad Miguel Hernández
(UMH), Elche 03202, Spain
- CIBER:
CB12/03/30038, Fisiopatología de la Obesidad y la Nutrición,
CIBERobn, Instituto de Salud Carlos III
(ISCIII), Madrid 28029, Spain
| |
Collapse
|
2
|
Biochemistry of Antioxidants: Mechanisms and Pharmaceutical Applications. Biomedicines 2022; 10:biomedicines10123051. [PMID: 36551806 PMCID: PMC9776363 DOI: 10.3390/biomedicines10123051] [Citation(s) in RCA: 46] [Impact Index Per Article: 15.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/03/2022] [Revised: 11/18/2022] [Accepted: 11/21/2022] [Indexed: 11/29/2022] Open
Abstract
Natural antioxidants from fruits and vegetables, meats, eggs and fish protect cells from the damage caused by free radicals. They are widely used to reduce food loss and waste, minimizing lipid oxidation, as well as for their effects on health through pharmaceutical preparations. In fact, the use of natural antioxidants is among the main efforts made to relieve the pressure on natural resources and to move towards more sustainable food and pharmaceutical systems. Alternative food waste management approaches include the valorization of by-products as a source of phenolic compounds for functional food formulations. In this review, we will deal with the chemistry of antioxidants, including their molecular structures and reaction mechanisms. The biochemical aspects will also be reviewed, including the effects of acidity and temperature on their partitioning in binary and multiphasic systems. The poor bioavailability of antioxidants remains a huge constraint for clinical applications, and we will briefly describe some delivery systems that provide for enhanced pharmacological action of antioxidants via drug targeting and increased bioavailability. The pharmacological activity of antioxidants can be improved by designing nanotechnology-based formulations, and recent nanoformulations include nanoparticles, polymeric micelles, liposomes/proliposomes, phytosomes and solid lipid nanoparticles, all showing promising outcomes in improving the efficiency and bioavailability of antioxidants. Finally, an overview of the pharmacological effects, therapeutic properties and future choice of antioxidants will be incorporated.
Collapse
|
3
|
Nikou T, Sakavitsi ME, Kalampokis E, Halabalaki M. Metabolism and Bioavailability of Olive Bioactive Constituents Based on In Vitro, In Vivo and Human Studies. Nutrients 2022; 14:3773. [PMID: 36145149 PMCID: PMC9504511 DOI: 10.3390/nu14183773] [Citation(s) in RCA: 19] [Impact Index Per Article: 6.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/08/2022] [Revised: 09/05/2022] [Accepted: 09/07/2022] [Indexed: 11/17/2022] Open
Abstract
Consumption of olive products has been established as a health-promoting dietary pattern due to their high content in compounds with eminent pharmacological properties and well-described bioactivities. However, their metabolism has not yet been fully described. The present critical review aimed to gather all scientific data of the past two decades regarding the absorption and metabolism of the foremost olive compounds, specifically of the phenylalcohols hydroxytyrosol (HTyr) and tyrosol (Tyr) and the secoiridoids oleacein (Olea), oleocanthal (Oleo) and oleuropein (Oleu). A meticulous record of the in vitro assays and in vivo (animals and humans) studies of the characteristic olive compounds was cited, and a critical discussion on their bioavailability and metabolism was performed taking into account data from their gut microbial metabolism. The existing critical review summarizes the existing knowledge regarding the bioavailability and metabolism of olive-characteristic phenylalchohols and secoiridoids and spotlights the lack of data for specific chemical groups and compounds. Critical observations and conclusions were derived from correlating structure with bioavailability data, while results from in vitro, animal and human studies were compared and discussed, giving significant insight to the future design of research approaches for the total bioavailability and metabolism exploration thereof.
Collapse
Affiliation(s)
| | | | | | - Maria Halabalaki
- Division of Pharmacognosy and Natural Products Chemistry, Department of Pharmacy, National and Kapodistrian University of Athens, 15771 Athens, Greece
| |
Collapse
|
4
|
Polia F, Horcajada MN, Poquet L, Tomás-Barberán FA, García-Villalba R. A novel combined analytical UV and MS approach for the quantification of oleuropein metabolites in human biological samples when authentic standards are not available. J Chromatogr B Analyt Technol Biomed Life Sci 2022; 1210:123457. [PMID: 36150306 DOI: 10.1016/j.jchromb.2022.123457] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/23/2022] [Revised: 09/06/2022] [Accepted: 09/07/2022] [Indexed: 11/27/2022]
Abstract
The beneficial health effects of phytochemicals depend on their bioavailability and the form under which they reach systemic circulation, usually as phase II metabolites. The lack of authentic standards for these metabolites makes their quantification in biological samples challenging. A new analytical approach to get a more accurate quantification of oleuropein metabolites in biological samples after ingestion of olive leaf extract was proposed. This approach was based on the calculation of a response factor in QTOF MS for each metabolite, comparing their quantification in UV and MS using urine samples concentrated in the metabolites of interest. Glucuronide and sulfate conjugates of hydroxytyrosol and homovanillyl alcohol were more accurately quantified in plasma and urine and for the first time, oleuropein aglycone conjugates and their hydroxylated and hydrogenated derivatives were quantified after consumption of olive products. This approach could be extensible to the analysis of other phenolic metabolites when authentic standards are not available, opening a valuable method for bioavailability studies.
Collapse
Affiliation(s)
- Franck Polia
- Laboratory of Food & Health, Research Group on Quality, Safety, and Bioactivity of Plant Foods, CEBAS-CSIC, Murcia, Spain.
| | - Marie-Noelle Horcajada
- Nestlé Institute of Health Sciences, Nestlé Research, Innovation EPFL Park, 1015 Lausanne, Switzerland.
| | - Laure Poquet
- Nestlé Institute of Health Sciences, Nestlé Research, Innovation EPFL Park, 1015 Lausanne, Switzerland.
| | - Francisco A Tomás-Barberán
- Laboratory of Food & Health, Research Group on Quality, Safety, and Bioactivity of Plant Foods, CEBAS-CSIC, Murcia, Spain.
| | - Rocío García-Villalba
- Laboratory of Food & Health, Research Group on Quality, Safety, and Bioactivity of Plant Foods, CEBAS-CSIC, Murcia, Spain.
| |
Collapse
|
5
|
Costa M, Costa V, Lopes M, Paiva-Martins F. A biochemical perspective on the fate of virgin olive oil phenolic compounds in vivo. Crit Rev Food Sci Nutr 2022; 64:1403-1428. [PMID: 36094444 DOI: 10.1080/10408398.2022.2116558] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
Abstract
The chemistry of the phenolic compounds found in virgin olive oil (VOO) is very complex due, not only to the different classes of polyphenols that can be found in it, but, above all, due to the existence of a very specific phenol class found only in oleaceae plants: the secoiridoids. Searching in the Scopus data base the keywords flavonoid, phenolic acid, lignin and secoiridoid, we can find a number of 148174, 79435, 11326 and 1392 research articles respectively, showing how little is devote to the latter class of compounds. Moreover, in contrast with other classes, that include only phenolic compounds, secoiridoids may include phenolic and non-phenolic compounds, being the articles concerning phenolic secoiridoids much less than the half of the abovementioned articles. Therefore, it is important to clarify the structures of these compounds and their chemistry, as this knowledge will help understand their bioactivity and metabolism studies, usually performed by researchers with a more health science's related background. In this review, all the structures found in many research articles concerning VOO phenolic compounds chemistry and metabolism was gathered, with a special attention devoted to the secoiridoids, the main phenolic compound class found in olives, VOO and olive leaf.
Collapse
Affiliation(s)
- Marlene Costa
- REQUIMTE-LAQV, Departamento de Química e Bioquímica, Faculdade de Ciências, Universidade do Porto, Porto, Portugal
| | - Vânia Costa
- REQUIMTE-LAQV, Departamento de Química e Bioquímica, Faculdade de Ciências, Universidade do Porto, Porto, Portugal
| | - Margarida Lopes
- REQUIMTE-LAQV, Departamento de Química e Bioquímica, Faculdade de Ciências, Universidade do Porto, Porto, Portugal
| | - Fátima Paiva-Martins
- REQUIMTE-LAQV, Departamento de Química e Bioquímica, Faculdade de Ciências, Universidade do Porto, Porto, Portugal
| |
Collapse
|
6
|
Placha I, Bacova K, Plachy L. Current Knowledge on the Bioavailability of Thymol as a Feed Additive in Humans and Animals with a Focus on Rabbit Metabolic Processes. Animals (Basel) 2022; 12:ani12091131. [PMID: 35565557 PMCID: PMC9104011 DOI: 10.3390/ani12091131] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/02/2022] [Revised: 04/22/2022] [Accepted: 04/26/2022] [Indexed: 01/26/2023] Open
Abstract
Simple Summary This review provides general information on the possible health benefits in animals and humans of herbal additives, particularly thymol, whose phenolic group is responsible for the neutralisation of free radicals, and information concerning its detection through body action, bioavailability and mechanisms in rabbits. Plants containing thymol have been used in traditional medicine for the treatment of various diseases, such as cardiovascular diseases, cancer and diabetes. Although a great number of in vitro studies of cardiovascular and cancer diseases are available, in vivo studies that confirm these findings have not been sufficiently reported. To determine the beneficial dose, further clinical studies are necessary, with preclinical comprehensive research on animal models. Abstract The aim of this review is to describe the therapeutic effect of thymol on various human diseases, followed by its bioavailability in humans and animals. Based on our knowledge from the current literature, after thymol addition, thymol metabolites—mostly thymol sulphate and glucuronide—are detected in the plasma and urine of humans and in the plasma, intestinal content, faeces and tissues in rats, pigs, chickens, horses and rabbits after enzymatic cleavage. In rabbits, thymol absorption from the gastrointestinal tract, its distribution within the organism, its accumulation in tissues and its excretion from the organism have been described in detail. It is necessary and important for these studies to suggest the appropriate dose needed to achieve the required health benefits not only for animals but also for humans. Information from this review concerning the mode of action of thymol in animal organisms could also be applied to human medicine and may help in the utilisation of herbal medicine in humans and in veterinary healthcare. This review summarises the important aspects of thymol’s effects on health and its bioavailability in organisms, particularly in rabbits. In future, herbal-based drugs must be extensively investigated in terms of their mode of action, efficiency of administration and clinical effect.
Collapse
Affiliation(s)
- Iveta Placha
- Centre of Biosciences of the Slovak Academy of Sciences, Institute of Animal Physiology, Soltesovej 4-6, 040 01 Kosice, Slovakia;
- Correspondence: ; Tel.: +421-55-792-2969
| | - Kristina Bacova
- Centre of Biosciences of the Slovak Academy of Sciences, Institute of Animal Physiology, Soltesovej 4-6, 040 01 Kosice, Slovakia;
- University of Veterinary Medicine and Pharmacy, Komenskeho 73, 041 81 Kosice, Slovakia
| | - Lukas Plachy
- 1st Department of Cardiology, East Slovak Institute of Cardiovascular Diseases, Ondavska 8, 040 11 Kosice, Slovakia;
- Faculty of Medicine, Pavol Jozef Safarik University in Kosice, Trieda SNP 457/1, 040 11 Kosice, Slovakia
| |
Collapse
|
7
|
Polyphenols as Antioxidants for Extending Food Shelf-Life and in the Prevention of Health Diseases: Encapsulation and Interfacial Phenomena. Biomedicines 2021; 9:biomedicines9121909. [PMID: 34944722 PMCID: PMC8698762 DOI: 10.3390/biomedicines9121909] [Citation(s) in RCA: 22] [Impact Index Per Article: 5.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/03/2021] [Revised: 11/25/2021] [Accepted: 12/02/2021] [Indexed: 01/23/2023] Open
Abstract
Toxicity caused by the exposure to human-made chemicals and environmental conditions has become a major health concern because they may significantly increase the formation of reactive oxygen species (ROS), negatively affecting the endogenous antioxidant defense. Living systems have evolved complex antioxidant mechanisms to protect cells from oxidative conditions. Although oxidative stress contributes to various pathologies, the intake of molecules such as polyphenols, obtained from natural sources, may limit their effects because of their antioxidant and antimicrobial properties against lipid peroxidation and against a broad range of foodborne pathogens. Ingestion of polyphenol-rich foods, such as fruits and vegetables, help to reduce the harmful effects of ROS, but the use of supramolecular and nanomaterials as delivery systems has emerged as an efficient method to improve their pharmacological and therapeutic effects. Suitable exogenous polyphenolic antioxidants should be readily absorbed and delivered to sites where pathological oxidative damage may take place, for instance, intracellular locations. Many potential antioxidants have a poor bioavailability, but they can be encapsulated to improve their ideal solubility and permeability profile. Development of effective antioxidant strategies requires the creation of new nanoscale drug delivery systems to significantly reduce oxidative stress. In this review we provide an overview of the oxidative stress process, highlight some properties of ROS, and discuss the role of natural polyphenols as bioactives in controlling the overproduction of ROS and bacterial and fungal growth, paying special attention to their encapsulation in suitable delivery systems and to their location in colloidal systems where interfaces play a crucial role.
Collapse
|
8
|
Bacova K, Eglseer KZ, Räuber GK, Chrastinova L, Laukova A, Takacsova M, Simonova MP, Placha I. Effect of Sustained Administration of Thymol on Its Bioaccessibility and Bioavailability in Rabbits. Animals (Basel) 2021; 11:ani11092595. [PMID: 34573560 PMCID: PMC8470628 DOI: 10.3390/ani11092595] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/03/2021] [Revised: 08/23/2021] [Accepted: 09/01/2021] [Indexed: 12/02/2022] Open
Abstract
Simple Summary The purpose of this study was to investigate the bioavailability and metabolic path of thymol, a major constituent of Thymus vulgaris L., in the rabbit organism. Oral bioavailability is a key parameter affecting the efficacy of substances, but it is not surprising that it does not correlate satisfactorily with efficacy. The main limitation factors are rate of absorption, metabolism, and excretion processes. In this work, the thymol metabolic path in the rabbit organism was determined for the first time after its sustained oral administration. We confirm intensive absorption of thymol from the gastrointestinal tract; our results point to metabolism and accumulation in kidney tissue and intensive metabolic and excretion processes in the liver. Some metabolic processes were present also after thymol withdrawal. Thymol as a lipophilic substance was found only in trace amounts in fat and muscle tissue as a consequence of its conversion into hydrophilic metabolite and greater elimination in the rabbit organism. This paper highlights the insufficient knowledge of modes of action of plant compounds in animal organisms. Abstract The objective of this study was the detection of thymol in rabbit plasma, tissues, large intestinal content, and faeces. Forty-eight rabbits were divided into control and experimental groups (thymol 250 mg/kg feed). Thymol was administered for 21 days and then withdrawn for 7 days. Concentration of thymol in the intestinal wall (IW) was significantly higher than in plasma (p < 0.05) and liver (p < 0.05); in the kidneys it was significantly higher than in plasma (p < 0.05) and liver (p < 0.05) during thymol addition. Thymol in IW was significantly higher than in plasma also after withdrawal (p < 0.01). Significant correlation (rs = −1.000, p < 0.01) between IW and plasma points to the intensive absorption of thymol from the intestine, while the correlation between plasma and liver (rs = 0.786, p < 0.05) indicates intensive biotransformation and excretion processes in liver. Significant correlation between liver and kidney (rs = 0.738, p < 0.05) confirms the intensive metabolism of thymol in the kidney. During the withdrawal period, thymol was detected above trace amounts only in faeces, and was significantly higher than in the colon during both periods (p < 0.01). Results show intensive biotransformation of thymol in the rabbit organism.
Collapse
Affiliation(s)
- Kristina Bacova
- Centre of Biosciences, Slovak Academy of Sciences, Institute of Animal Physiology, Soltesovej 4-6, 040 01 Kosice, Slovakia; (K.B.); (A.L.); (M.T.); (M.P.S.)
- University of Veterinary Medicine and Pharmacy, Komenskeho 73, 041 81 Kosice, Slovakia
| | - Karin Zitterl Eglseer
- Institute of Animal Nutrition and Functional Plant Compounds, University of Veterinary Medicine Vienna, Veterinärplatz 1, A-1210 Wien, Austria; (K.Z.E.); (G.K.R.)
| | - Gesine Karas Räuber
- Institute of Animal Nutrition and Functional Plant Compounds, University of Veterinary Medicine Vienna, Veterinärplatz 1, A-1210 Wien, Austria; (K.Z.E.); (G.K.R.)
| | - Lubica Chrastinova
- National Agricultural and Food Centre, Hlohovecka 2, 951 41 Nitra-Lužianky, Slovakia;
| | - Andrea Laukova
- Centre of Biosciences, Slovak Academy of Sciences, Institute of Animal Physiology, Soltesovej 4-6, 040 01 Kosice, Slovakia; (K.B.); (A.L.); (M.T.); (M.P.S.)
| | - Margareta Takacsova
- Centre of Biosciences, Slovak Academy of Sciences, Institute of Animal Physiology, Soltesovej 4-6, 040 01 Kosice, Slovakia; (K.B.); (A.L.); (M.T.); (M.P.S.)
| | - Monika Pogany Simonova
- Centre of Biosciences, Slovak Academy of Sciences, Institute of Animal Physiology, Soltesovej 4-6, 040 01 Kosice, Slovakia; (K.B.); (A.L.); (M.T.); (M.P.S.)
| | - Iveta Placha
- Centre of Biosciences, Slovak Academy of Sciences, Institute of Animal Physiology, Soltesovej 4-6, 040 01 Kosice, Slovakia; (K.B.); (A.L.); (M.T.); (M.P.S.)
- Correspondence: ; Tel.: +421-55-792-2969
| |
Collapse
|
9
|
Phenol Biological Metabolites as Food Intake Biomarkers, a Pending Signature for a Complete Understanding of the Beneficial Effects of the Mediterranean Diet. Nutrients 2021; 13:nu13093051. [PMID: 34578929 PMCID: PMC8471182 DOI: 10.3390/nu13093051] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/07/2021] [Revised: 08/11/2021] [Accepted: 08/20/2021] [Indexed: 01/14/2023] Open
Abstract
The Mediterranean diet (MD) has become a dietary pattern of reference due to its preventive effects against chronic diseases, especially relevant in cardiovascular diseases (CVD). Establishing an objective tool to determine the degree of adherence to the MD is a pending task and deserves consideration. The central axis that distinguishes the MD from other dietary patterns is the choice and modality of food consumption. Identification of intake biomarkers of commonly consumed foods is a key strategy for estimating the degree of adherence to the MD and understanding the protective mechanisms that lead to a positive impact on health. Throughout this review we propose potential candidates to be validated as MD adherence biomarkers, with particular focus on the metabolites derived from the phenolic compounds that are associated with the consumption of typical Mediterranean plant foods. Certain phenolic metabolites are good indicators of the intake of specific foods, but others denote the intake of a wide-range of foods. For this, it is important to emphasise the need to increase the number of dietary interventions with specific foods in order to validate the biomarkers of MD adherence. Moreover, the identification and quantification of food phenolic intake biomarkers encouraging scientific research focuses on the study of the biological mechanisms in which polyphenols are involved.
Collapse
|
10
|
Vijakumaran U, Yazid MD, Hj Idrus RB, Abdul Rahman MR, Sulaiman N. Molecular Action of Hydroxytyrosol in Attenuation of Intimal Hyperplasia: A Scoping Review. Front Pharmacol 2021; 12:663266. [PMID: 34093194 PMCID: PMC8176091 DOI: 10.3389/fphar.2021.663266] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/02/2021] [Accepted: 04/29/2021] [Indexed: 12/28/2022] Open
Abstract
Objective: Hydroxytyrosol (HT), a polyphenol of olive plant is well known for its antioxidant, anti-inflammatory and anti-atherogenic properties. The aim of this systematic search is to highlight the scientific evidence evaluating molecular efficiency of HT in halting the progression of intimal hyperplasia (IH), which is a clinical condition arises from endothelial inflammation. Methods: A systematic search was performed through PubMed, Web of Science and Scopus, based on pre-set keywords which are Hydroxytyrosol OR 3,4-dihydroxyphenylethanol, AND Intimal hyperplasia OR Neointimal hyperplasia OR Endothelial OR Smooth muscles. Eighteen in vitro and three in vitro and in vivo studies were selected based on a pre-set inclusion and exclusion criteria. Results: Based on evidence gathered, HT was found to upregulate PI3K/AKT/mTOR pathways and supresses inflammatory factors and mediators such as IL-1β, IL-6, E-selectin, P-selectin, VCAM-1, and ICAM-1 in endothelial vascularization and functioning. Two studies revealed HT disrupted vascular smooth muscle cells (SMC) cell cycle by dephosphorylating ERK1/2 and AKT pathways. Therefore, HT was proven to promote endothelization and inhibit vascular SMCs migration thus hampering IH development. However, none of these studies described the effect of HT collectively in both vascular endothelial cells (EC) and SMCs in IH ex vivo model. Conclusions: Evidence from this concise review provides an insight on HT regulation of molecular pathways in reendothelization and inhibition of VSMCs migration. Henceforth, we propose effect of HT on IH prevention could be further elucidated through in vivo and ex vivo model.
Collapse
Affiliation(s)
- Ubashini Vijakumaran
- Centre for Tissue Engineering and Regenerative Medicine, Universiti Kebangsaan Malaysia Medical Centre, Kuala Lumpur, Malaysia
| | - Muhammad Dain Yazid
- Centre for Tissue Engineering and Regenerative Medicine, Universiti Kebangsaan Malaysia Medical Centre, Kuala Lumpur, Malaysia
| | - Ruszymah Bt Hj Idrus
- Centre for Tissue Engineering and Regenerative Medicine, Universiti Kebangsaan Malaysia Medical Centre, Kuala Lumpur, Malaysia
- Department of Physiology, Faculty of Medicine, Universiti Kebangsaan Malaysia Medical Centre, Kuala Lumpur, Malaysia
| | - Mohd Ramzisham Abdul Rahman
- Department of Surgery, Faculty of Medicine, Universiti Kebangsaan Malaysia Medical Centre, Kuala Lumpur, Malaysia
| | - Nadiah Sulaiman
- Centre for Tissue Engineering and Regenerative Medicine, Universiti Kebangsaan Malaysia Medical Centre, Kuala Lumpur, Malaysia
| |
Collapse
|
11
|
López-Yerena A, Pérez M, Vallverdú-Queralt A, Miliarakis E, Lamuela-Raventós RM, Escribano-Ferrer E. Oleacein Intestinal Permeation and Metabolism in Rats Using an In Situ Perfusion Technique. Pharmaceutics 2021; 13:719. [PMID: 34068871 PMCID: PMC8153610 DOI: 10.3390/pharmaceutics13050719] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/27/2021] [Revised: 05/11/2021] [Accepted: 05/12/2021] [Indexed: 12/27/2022] Open
Abstract
Oleacein (OLEA) is one of the most important phenolic compounds in extra virgin olive oil in terms of concentration and health-promoting properties, yet there are insufficient data on its absorption and metabolism. Several non-human models have been developed to assess the intestinal permeability of drugs, among them, single-pass intestinal perfusion (SPIP), which is commonly used to investigate the trans-membrane transport of drugs in situ. In this study, the SPIP model and simultaneous luminal blood sampling were used to study the absorption and metabolism of OLEA in rats. Samples of intestinal fluid and mesenteric blood were taken at different times and the ileum segment was excised at the end of the experiment for analysis by LC-ESI-LTQ-Orbitrap-MS. OLEA was mostly metabolized by phase I reactions, undergoing hydrolysis and oxidation, and metabolite levels were much higher in the plasma than in the lumen. The large number of metabolites identified and their relatively high abundance indicates an important intestinal first-pass effect during absorption. According to the results, OLEA is well absorbed in the intestine, with an intestinal permeability similar to that of the highly permeable model compound naproxen. No significant differences were found in the percentage of absorbed OLEA and naproxen (48.98 ± 12.27% and 43.96 ± 7.58%, respectively).
Collapse
Affiliation(s)
- Anallely López-Yerena
- Department of Nutrition, Food Science and Gastronomy XaRTA, Faculty of Pharmacy and Food Sciences, Institute of Nutrition and Food Safety (INSA-UB), University of Barcelona, 08028 Barcelona, Spain; (A.L.-Y.); (M.P.); (A.V.-Q.); (R.M.L.-R.)
| | - Maria Pérez
- Department of Nutrition, Food Science and Gastronomy XaRTA, Faculty of Pharmacy and Food Sciences, Institute of Nutrition and Food Safety (INSA-UB), University of Barcelona, 08028 Barcelona, Spain; (A.L.-Y.); (M.P.); (A.V.-Q.); (R.M.L.-R.)
- Laboratory of Organic Chemistry, Faculty of Pharmacy and Food Sciences, University of Barcelona, 08028 Barcelona, Spain
| | - Anna Vallverdú-Queralt
- Department of Nutrition, Food Science and Gastronomy XaRTA, Faculty of Pharmacy and Food Sciences, Institute of Nutrition and Food Safety (INSA-UB), University of Barcelona, 08028 Barcelona, Spain; (A.L.-Y.); (M.P.); (A.V.-Q.); (R.M.L.-R.)
- CIBER Physiopathology of Obesity and Nutrition (CIBEROBN), Institute of Health Carlos III, 28029 Madrid, Spain
| | | | - Rosa M. Lamuela-Raventós
- Department of Nutrition, Food Science and Gastronomy XaRTA, Faculty of Pharmacy and Food Sciences, Institute of Nutrition and Food Safety (INSA-UB), University of Barcelona, 08028 Barcelona, Spain; (A.L.-Y.); (M.P.); (A.V.-Q.); (R.M.L.-R.)
- CIBER Physiopathology of Obesity and Nutrition (CIBEROBN), Institute of Health Carlos III, 28029 Madrid, Spain
| | - Elvira Escribano-Ferrer
- CIBER Physiopathology of Obesity and Nutrition (CIBEROBN), Institute of Health Carlos III, 28029 Madrid, Spain
- Biopharmaceutics and Pharmacokinetics Unit, Department of Pharmacy and Pharmaceutical Technology and Physical Chemistry, Faculty of Pharmacy and Food Sciences, Institute of Nanoscience and Nanotechnology (IN2UB), University of Barcelona, 08028 Barcelona, Spain
- Pharmaceutical Nanotechnology Group I+D+I Associated Unit to CSIC, University of Barcelona, 08028 Barcelona, Spain
| |
Collapse
|
12
|
Galmés S, Reynés B, Palou M, Palou-March A, Palou A. Absorption, Distribution, Metabolism, and Excretion of the Main Olive Tree Phenols and Polyphenols: A Literature Review. JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY 2021; 69:5281-5296. [PMID: 33908772 DOI: 10.1021/acs.jafc.1c00737] [Citation(s) in RCA: 22] [Impact Index Per Article: 5.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/12/2023]
Abstract
The effects of olive tree (poly)phenols (OPs) are largely dependent upon their bioavailability and metabolization by humans. Absorption, distribution, metabolism, and excretion (ADME) are fundamental for the nutritional efficacy and toxicological impact of foods containing OPs. This review includes studies on the administration of hydroxytyrosol (HT), oleuropein (Ole), or other OPs and foods, products, or mixtures that contain them. Briefly, data from in vivo studies indicate that OPs are absorbable by intestinal cells. Both absorption and bioavailability depend upon each compound and/or the matrix in which it is contained. OPs metabolism begins in enterocytes and can also continue in the liver. Metabolic phase I mainly consists of the hydrolysis of Ole, which results in an increase in the HT content. Phase II metabolic reactions involve the conjugation of (poly)phenols mainly with glucuronide and sulfate groups. This review offers a complete perspective of the ADME processes of OPs, which could support the future nutritional and/or toxicological studies in this area.
Collapse
Affiliation(s)
- Sebastià Galmés
- Alimentómica S.L., 07121 Palma de Mallorca, Balearic Islands, Spain
- Laboratory of Molecular Biology, Nutrition and Biotechnology (Group of Nutrigenomics and Obesity), University of the Balearic Islands (UIB) and Instituto de Investigación Sanitaria Illes Balears (IdISBa), 07122 Palma de Mallorca, Balearic Islands, Spain
- CIBER de Fisiopatología de la Obesidad y Nutrición (CIBERobn), 28029 Madrid, Spain
| | - Bàrbara Reynés
- Alimentómica S.L., 07121 Palma de Mallorca, Balearic Islands, Spain
- Laboratory of Molecular Biology, Nutrition and Biotechnology (Group of Nutrigenomics and Obesity), University of the Balearic Islands (UIB) and Instituto de Investigación Sanitaria Illes Balears (IdISBa), 07122 Palma de Mallorca, Balearic Islands, Spain
| | - Mariona Palou
- Alimentómica S.L., 07121 Palma de Mallorca, Balearic Islands, Spain
- Laboratory of Molecular Biology, Nutrition and Biotechnology (Group of Nutrigenomics and Obesity), University of the Balearic Islands (UIB) and Instituto de Investigación Sanitaria Illes Balears (IdISBa), 07122 Palma de Mallorca, Balearic Islands, Spain
- CIBER de Fisiopatología de la Obesidad y Nutrición (CIBERobn), 28029 Madrid, Spain
| | - Andreu Palou-March
- Alimentómica S.L., 07121 Palma de Mallorca, Balearic Islands, Spain
- Laboratory of Molecular Biology, Nutrition and Biotechnology (Group of Nutrigenomics and Obesity), University of the Balearic Islands (UIB) and Instituto de Investigación Sanitaria Illes Balears (IdISBa), 07122 Palma de Mallorca, Balearic Islands, Spain
- CIBER de Fisiopatología de la Obesidad y Nutrición (CIBERobn), 28029 Madrid, Spain
| | - Andreu Palou
- Alimentómica S.L., 07121 Palma de Mallorca, Balearic Islands, Spain
- Laboratory of Molecular Biology, Nutrition and Biotechnology (Group of Nutrigenomics and Obesity), University of the Balearic Islands (UIB) and Instituto de Investigación Sanitaria Illes Balears (IdISBa), 07122 Palma de Mallorca, Balearic Islands, Spain
- CIBER de Fisiopatología de la Obesidad y Nutrición (CIBERobn), 28029 Madrid, Spain
| |
Collapse
|
13
|
López-Yerena A, Vallverdú-Queralt A, Jáuregui O, Garcia-Sala X, Lamuela-Raventós RM, Escribano-Ferrer E. Tissue Distribution of Oleocanthal and Its Metabolites after Oral Ingestion in Rats. Antioxidants (Basel) 2021; 10:688. [PMID: 33925686 PMCID: PMC8146289 DOI: 10.3390/antiox10050688] [Citation(s) in RCA: 16] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/08/2021] [Revised: 04/23/2021] [Accepted: 04/25/2021] [Indexed: 12/11/2022] Open
Abstract
Claims for the potential health benefits of oleocanthal (OLC), a dietary phenolic compound found in olive oil, are based mainly on in vitro studies. Little is known about the tissue availability of OLC, which is rapidly metabolized after ingestion. In this study, the distribution of OLC and its metabolites in rat plasma and tissues (stomach, intestine, liver, kidney, spleen, lungs, heart, brain, thyroid and skin) at 1, 2 and 4.5 h after the acute intake of a refined olive oil containing 0.3 mg/mL of OLC was examined by LC-ESI-LTQ-Orbitrap-MS. OLC was only detected in the stomach and intestine samples. Moreover, at 2 and 4.5 h, the concentration in the stomach decreased by 36% and 74%, respectively, and in the intestine by 16% and 33%, respectively. Ten OLC metabolites arising from phase I and phase II reactions were identified. The metabolites were widely distributed in rat tissues, and the most important metabolizing organs were the small intestine and liver. The two main circulating metabolites were the conjugates OLC + OH + CH3 and OLC + H2O + glucuronic acid, which may significantly contribute to the beneficial health effects associated with the regular consumption of extra virgin olive oil. However, more studies are necessary to determine the concentrations and molecular structures of OLC metabolites in human plasma and tissues when consumed with the presence of other phenolic compunds present in EVOO.
Collapse
Affiliation(s)
- Anallely López-Yerena
- Department of Nutrition, Food Science and Gastronomy XaRTA, Faculty of Pharmacy and Food Sciences, Institute of Nutrition and Food Safety (INSA-UB), University of Barcelona, 08028 Barcelona, Spain; (A.L.-Y.); (A.V.-Q.); (R.M.L.-R.)
| | - Anna Vallverdú-Queralt
- Department of Nutrition, Food Science and Gastronomy XaRTA, Faculty of Pharmacy and Food Sciences, Institute of Nutrition and Food Safety (INSA-UB), University of Barcelona, 08028 Barcelona, Spain; (A.L.-Y.); (A.V.-Q.); (R.M.L.-R.)
- CIBER Physiopathology of Obesity and Nutrition (CIBEROBN), Institute of Health Carlos III, 28029 Madrid, Spain
| | - Olga Jáuregui
- Scientific and Technological Center of University of Barcelona (CCiTUB), 08028 Barcelona, Spain;
| | - Xavier Garcia-Sala
- Biopharmaceutics and Pharmacokinetics Unit, Department of Pharmacy and Pharmaceutical Technology and Physical Chemistry, Institute of Nanoscience and Nanotechnology (IN2UB), Faculty of Pharmacy and Food Sciences, University of Barcelona, 08028 Barcelona, Spain;
| | - Rosa M. Lamuela-Raventós
- Department of Nutrition, Food Science and Gastronomy XaRTA, Faculty of Pharmacy and Food Sciences, Institute of Nutrition and Food Safety (INSA-UB), University of Barcelona, 08028 Barcelona, Spain; (A.L.-Y.); (A.V.-Q.); (R.M.L.-R.)
- CIBER Physiopathology of Obesity and Nutrition (CIBEROBN), Institute of Health Carlos III, 28029 Madrid, Spain
| | - Elvira Escribano-Ferrer
- CIBER Physiopathology of Obesity and Nutrition (CIBEROBN), Institute of Health Carlos III, 28029 Madrid, Spain
- Biopharmaceutics and Pharmacokinetics Unit, Department of Pharmacy and Pharmaceutical Technology and Physical Chemistry, Institute of Nanoscience and Nanotechnology (IN2UB), Faculty of Pharmacy and Food Sciences, University of Barcelona, 08028 Barcelona, Spain;
- Pharmaceutical Nanotechnology Group I+D+I Associated Unit to CSIC, University of Barcelona, 08028 Barcelona, Spain
| |
Collapse
|
14
|
Oliverio M, Nardi M, Di Gioia ML, Costanzo P, Bonacci S, Mancuso S, Procopio A. Semi-synthesis as a tool for broadening the health applications of bioactive olive secoiridoids: a critical review. Nat Prod Rep 2020; 38:444-469. [PMID: 33300916 DOI: 10.1039/d0np00084a] [Citation(s) in RCA: 10] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/28/2022]
Abstract
Covering: 2005 up to 2020Olive bioactive secoiridoids are recognized as natural antioxidants with multiple beneficial effects on human health. Nevertheless, the study of their biological activity has also disclosed some critical aspects associated with their application. Firstly, only a few of them can be extracted in large amounts from their natural matrix, namely olive leaves, drupes, oil and olive mill wastewater. Secondly, their application as preventive agents and drugs is limited by their low membrane permeability. Thirdly, the study of their biological fate after administration is complicated by the absence of pure analytical standards. Accordingly, efficient synthetic methods to obtain natural and non-natural bioactive phenol derivatives have been developed. Among them, semi-synthetic protocols represent efficient and economical alternatives to total synthesis, combining efficient extraction protocols with efficient catalytic conversions to achieve reasonable amounts of active molecules. The aim of this review is to summarize the semi-synthetic protocols published in the last fifteen years, covering 2005 up to 2020, which can produce natural olive bioactive phenols scarcely available by extractive procedures, and new biophenol derivatives with enhanced biological activity. Moreover, the semi-synthetic protocols to produce olive bioactive phenol derivatives as analytical standards are also discussed. A critical analysis of the advantages offered by semi-synthesis compared to classical extraction methods or total synthesis protocols is also performed.
Collapse
Affiliation(s)
- Manuela Oliverio
- Department of Health Sciences, University Magna Graecia, Catanzaro, Italy.
| | | | | | | | | | | | | |
Collapse
|
15
|
Fernandes S, Ribeiro C, Paiva-Martins F, Catarino C, Santos-Silva A. Protective effect of olive oil polyphenol phase II sulfate conjugates on erythrocyte oxidative-induced hemolysis. Food Funct 2020; 11:8670-8679. [PMID: 32939526 DOI: 10.1039/d0fo01690j] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
Abstract
The consumption of extra virgin olive oil (EVOO) has been associated with a lower incidence of cardiovascular diseases partly due to its polyphenol content. The metabolites hydroxytyrosol sulfate and hydroxytyrosol acetate sulfate were shown to be the most concentrated polyphenol metabolites found in plasma after EVOO consumption. Therefore, the capacity of hydroxytyrosol, hydroxytyrosol acetate, homovanillyl alcohol, homovanillyl alcohol acetate and tyrosol sulfate metabolites, to protect red blood cells (RBCs) from oxidative injury induced by the radical initiator 2,2'-azo-bis(2-amidinopropane) dihydrochloride (AAPH) was evaluated. In the presence of AAPH, all non-sulfated compounds and the hydroxytyrosol and hydroxytyrosol acetate monosulfate metabolites showed a significant protective activity against RBCs induced oxidative hemolysis. Moreover, even at 5 μM, the protection was highly significant for hydroxytyrosol acetate, hydroxytyrosol and hydroxytyrosol acetate 3' and 4' monosulfates. The morphological changes of RBC and the nature of their hemoglobin were in accordance with the hemolysis assay. Results showed that a free phenolic hydroxyl group is needed for the antioxidant protection given by compounds. Hydroxytyrosol metabolites present as phase II sulfate conjugates are actually able to protect RBC from oxidative injury by a non-transcriptional mechanism and are likely to contribute for the anti-atherosclerosis properties of regular EVOO consumption.
Collapse
Affiliation(s)
- Sara Fernandes
- REQUIMTE-LAQV, Departamento de Química e Bioquímica, Faculdade de Ciências, Universidade do Porto, Rua do Campo Alegre, 687, 4169-007 Porto, Portugal.
| | - Catarina Ribeiro
- REQUIMTE-LAQV, Departamento de Química e Bioquímica, Faculdade de Ciências, Universidade do Porto, Rua do Campo Alegre, 687, 4169-007 Porto, Portugal.
| | - Fátima Paiva-Martins
- REQUIMTE-LAQV, Departamento de Química e Bioquímica, Faculdade de Ciências, Universidade do Porto, Rua do Campo Alegre, 687, 4169-007 Porto, Portugal.
| | - Cristina Catarino
- REQUIMTE-UCIBIO, Serviço de Bioquímica, Departamento de Ciências Biológicas, Faculdade de Farmácia, Universidade do Porto, Portugal
| | - Alice Santos-Silva
- REQUIMTE-UCIBIO, Serviço de Bioquímica, Departamento de Ciências Biológicas, Faculdade de Farmácia, Universidade do Porto, Portugal
| |
Collapse
|
16
|
Cedó L, Fernández-Castillejo S, Rubió L, Metso J, Santos D, Muñoz-Aguayo D, Rivas-Urbina A, Tondo M, Méndez-Lara KA, Farràs M, Jauhiainen M, Motilva MJ, Fitó M, Blanco-Vaca F, Solà R, Escolà-Gil JC. Phenol-Enriched Virgin Olive Oil Promotes Macrophage-Specific Reverse Cholesterol Transport In Vivo. Biomedicines 2020; 8:E266. [PMID: 32756328 PMCID: PMC7460104 DOI: 10.3390/biomedicines8080266] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/16/2020] [Revised: 07/28/2020] [Accepted: 07/29/2020] [Indexed: 12/16/2022] Open
Abstract
The intake of olive oil (OO) enriched with phenolic compounds (PCs) promotes ex vivo HDL-mediated macrophage cholesterol efflux in humans. We aimed to determine the effects of PC-enriched virgin OO on reverse cholesterol transport (RevCT) from macrophages to feces in vivo. Female C57BL/6 mice were given intragastric doses of refined OO (ROO) and a functional unrefined virgin OO enriched with its own PC (FVOO) for 14 days. Our experiments included two independent groups of mice that received intragastric doses of the phenolic extract (PE) used to prepare the FVOO and the vehicle solution (saline), as control, for 14 days. FVOO intake led to a significant increase in serum HDL cholesterol and its ability to induce macrophage cholesterol efflux in vitro when compared with ROO group. This was concomitant with the enhanced macrophage-derived [3H]cholesterol transport to feces in vivo. PE intake per se also increased HDL cholesterol levels and significantly promoted in vivo macrophage-to-feces RevCT rate when compared with saline group. PE upregulated the expression of the main macrophage transporter involved in macrophage cholesterol efflux, the ATP binding cassettea1. Our data provide direct evidence of the crucial role of OO PCs in the induction of macrophage-specific RevCT in vivo.
Collapse
Affiliation(s)
- Lídia Cedó
- Institut d’Investigacions Biomèdiques IIB Sant Pau, 08041 Barcelona, Spain; (D.S.); (A.R.-U.); (M.T.); (K.A.M.-L.); (M.F.); (F.B.-V.)
- CIBER de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), 28029 Madrid, Spain
| | - Sara Fernández-Castillejo
- Surgery Department-Functional Nutrition, Oxidation, and CVD Research Group (NFOC-Salut), Faculty of Medicine and Health Sciences-Medicine, Universitat Rovira i Virgili, 43201 Reus, Spain; (S.F.-C.); (L.R.); (R.S.)
- Fundació EURECAT—Centre Tecnològic de Nutrició i Salut, 43204 Reus, Spain
| | - Laura Rubió
- Surgery Department-Functional Nutrition, Oxidation, and CVD Research Group (NFOC-Salut), Faculty of Medicine and Health Sciences-Medicine, Universitat Rovira i Virgili, 43201 Reus, Spain; (S.F.-C.); (L.R.); (R.S.)
- Food Technology Department, Universitat de Lleida-Agrotecnio Center, 25198 Lleida, Spain
| | - Jari Metso
- Minerva Foundation Institute for Medical Research and National Institute for Health and Welfare, Genomics and Biomarkers Unit, 00290 Helsinki, Finland; (J.M.); (M.J.)
| | - David Santos
- Institut d’Investigacions Biomèdiques IIB Sant Pau, 08041 Barcelona, Spain; (D.S.); (A.R.-U.); (M.T.); (K.A.M.-L.); (M.F.); (F.B.-V.)
- CIBER de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), 28029 Madrid, Spain
| | - Daniel Muñoz-Aguayo
- IMIM Hospital del Mar Medical Research Institute, Grup de Risc Cardiovascular i Nutrició, 08003 Barcelona, Spain; (D.M.-A.); (M.F.)
- CIBER of Physiopathology of Obesity and Nutrition CIBEROBN, Grup de Risc Cardiovascular i Nutrició, 28029 Madrid, Spain
| | - Andrea Rivas-Urbina
- Institut d’Investigacions Biomèdiques IIB Sant Pau, 08041 Barcelona, Spain; (D.S.); (A.R.-U.); (M.T.); (K.A.M.-L.); (M.F.); (F.B.-V.)
- Departament de Bioquímica i Biologia Molecular, Universitat Autònoma de Barcelona, 08041 Barcelona, Spain
| | - Mireia Tondo
- Institut d’Investigacions Biomèdiques IIB Sant Pau, 08041 Barcelona, Spain; (D.S.); (A.R.-U.); (M.T.); (K.A.M.-L.); (M.F.); (F.B.-V.)
| | - Karen Alejandra Méndez-Lara
- Institut d’Investigacions Biomèdiques IIB Sant Pau, 08041 Barcelona, Spain; (D.S.); (A.R.-U.); (M.T.); (K.A.M.-L.); (M.F.); (F.B.-V.)
- Departament de Bioquímica i Biologia Molecular, Universitat Autònoma de Barcelona, 08041 Barcelona, Spain
| | - Marta Farràs
- Institut d’Investigacions Biomèdiques IIB Sant Pau, 08041 Barcelona, Spain; (D.S.); (A.R.-U.); (M.T.); (K.A.M.-L.); (M.F.); (F.B.-V.)
- CIBER de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), 28029 Madrid, Spain
| | - Matti Jauhiainen
- Minerva Foundation Institute for Medical Research and National Institute for Health and Welfare, Genomics and Biomarkers Unit, 00290 Helsinki, Finland; (J.M.); (M.J.)
| | - Maria-José Motilva
- Instituto de Ciencias de la Vid y del Vino-ICVV (CSIC-Universidad de La Rioja-Gobierno de La Rioja), Finca “La Grajera”, 26007 Logroño, La Rioja, Spain;
| | - Montserrat Fitó
- IMIM Hospital del Mar Medical Research Institute, Grup de Risc Cardiovascular i Nutrició, 08003 Barcelona, Spain; (D.M.-A.); (M.F.)
- CIBER of Physiopathology of Obesity and Nutrition CIBEROBN, Grup de Risc Cardiovascular i Nutrició, 28029 Madrid, Spain
| | - Francisco Blanco-Vaca
- Institut d’Investigacions Biomèdiques IIB Sant Pau, 08041 Barcelona, Spain; (D.S.); (A.R.-U.); (M.T.); (K.A.M.-L.); (M.F.); (F.B.-V.)
- CIBER de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), 28029 Madrid, Spain
- Departament de Bioquímica i Biologia Molecular, Universitat Autònoma de Barcelona, 08041 Barcelona, Spain
| | - Rosa Solà
- Surgery Department-Functional Nutrition, Oxidation, and CVD Research Group (NFOC-Salut), Faculty of Medicine and Health Sciences-Medicine, Universitat Rovira i Virgili, 43201 Reus, Spain; (S.F.-C.); (L.R.); (R.S.)
- Fundació EURECAT—Centre Tecnològic de Nutrició i Salut, 43204 Reus, Spain
- Hospital Universitari Sant Joan de Reus HUSJR, NFOC-Salut, 43204 Reus, Spain
| | - Joan Carles Escolà-Gil
- Institut d’Investigacions Biomèdiques IIB Sant Pau, 08041 Barcelona, Spain; (D.S.); (A.R.-U.); (M.T.); (K.A.M.-L.); (M.F.); (F.B.-V.)
- CIBER de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), 28029 Madrid, Spain
- Departament de Bioquímica i Biologia Molecular, Universitat Autònoma de Barcelona, 08041 Barcelona, Spain
| |
Collapse
|
17
|
Pinarli B, Simge Karliga E, Ozkan G, Capanoglu E. Interaction of phenolics with food matrix: In vitro and in vivo approaches. MEDITERRANEAN JOURNAL OF NUTRITION AND METABOLISM 2020. [DOI: 10.3233/mnm-190362] [Citation(s) in RCA: 11] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
Affiliation(s)
- Beril Pinarli
- Department of Food Engineering, Faculty of Chemical and Metallurgical Engineering, Istanbul Technical University, Maslak, Istanbul, Turkey
| | - E. Simge Karliga
- Department of Food Engineering, Faculty of Chemical and Metallurgical Engineering, Istanbul Technical University, Maslak, Istanbul, Turkey
| | - Gulay Ozkan
- Department of Food Engineering, Faculty of Chemical and Metallurgical Engineering, Istanbul Technical University, Maslak, Istanbul, Turkey
| | - Esra Capanoglu
- Department of Food Engineering, Faculty of Chemical and Metallurgical Engineering, Istanbul Technical University, Maslak, Istanbul, Turkey
| |
Collapse
|
18
|
Lozano-Castellón J, López-Yerena A, Rinaldi de Alvarenga JF, Romero Del Castillo-Alba J, Vallverdú-Queralt A, Escribano-Ferrer E, Lamuela-Raventós RM. Health-promoting properties of oleocanthal and oleacein: Two secoiridoids from extra-virgin olive oil. Crit Rev Food Sci Nutr 2019; 60:2532-2548. [PMID: 31423808 DOI: 10.1080/10408398.2019.1650715] [Citation(s) in RCA: 65] [Impact Index Per Article: 10.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/19/2022]
Abstract
Extra virgin olive oil (EVOO) polyphenols, including the secoiridoids oleocanthal (OLC) and oleacein (OLE), are attracting attention because of their beneficial effects on health. Data on OLC and OLE bioavailability are scarce, as most research on EVOO polyphenols has concentrated on hydroxytyrosol, tyrosol, and oleuropein. Consequently, relevant goals for future research are the elucidation of OLC and OLE bioavailability and finding evidence for their beneficial effects through pre-clinical and clinical studies. The aim of this review is to shed light on OLC and OLE, focusing on their precursors in the olive fruit and the impact of agronomic and processing factors on their presence in EVOO. Also discussed are their bioavailability and absorption, and finally, their bioactivity and health-promoting properties.
Collapse
Affiliation(s)
- Julián Lozano-Castellón
- Nutrition, Food Science and Gastronomy Department, XaRTA, Institute of Nutrition and Food Safety (INSA-UB), School of Pharmacy and Food Sciences, University of Barcelona, Barcelona, Spain.,CIBER Physiopathology of Obesity and Nutrition (CIBEROBN), Institute of Health Carlos III, Madrid, Spain
| | - Anallely López-Yerena
- Nutrition, Food Science and Gastronomy Department, XaRTA, Institute of Nutrition and Food Safety (INSA-UB), School of Pharmacy and Food Sciences, University of Barcelona, Barcelona, Spain
| | - José Fernando Rinaldi de Alvarenga
- Nutrition, Food Science and Gastronomy Department, XaRTA, Institute of Nutrition and Food Safety (INSA-UB), School of Pharmacy and Food Sciences, University of Barcelona, Barcelona, Spain
| | - Jaume Romero Del Castillo-Alba
- Nutrition, Food Science and Gastronomy Department, XaRTA, Institute of Nutrition and Food Safety (INSA-UB), School of Pharmacy and Food Sciences, University of Barcelona, Barcelona, Spain
| | - Anna Vallverdú-Queralt
- Nutrition, Food Science and Gastronomy Department, XaRTA, Institute of Nutrition and Food Safety (INSA-UB), School of Pharmacy and Food Sciences, University of Barcelona, Barcelona, Spain.,CIBER Physiopathology of Obesity and Nutrition (CIBEROBN), Institute of Health Carlos III, Madrid, Spain
| | - Elvira Escribano-Ferrer
- CIBER Physiopathology of Obesity and Nutrition (CIBEROBN), Institute of Health Carlos III, Madrid, Spain.,Department of Pharmacy and Pharmaceutical Technology and Physical Chemistry, Biopharmaceutics and Pharmacokinetics Unit, Institute of Nanoscience and Nanotechnology (IN2UB), Pharmacy and Food Sciences School, University of Barcelona, Barcelona, Spain
| | - Rosa M Lamuela-Raventós
- Nutrition, Food Science and Gastronomy Department, XaRTA, Institute of Nutrition and Food Safety (INSA-UB), School of Pharmacy and Food Sciences, University of Barcelona, Barcelona, Spain.,CIBER Physiopathology of Obesity and Nutrition (CIBEROBN), Institute of Health Carlos III, Madrid, Spain
| |
Collapse
|
19
|
Begines P, Biedermann D, Valentová K, Petrásková L, Pelantová H, Maya I, Fernández-Bolaños JG, Křen V. Chemoenzymatic Synthesis and Radical Scavenging of Sulfated Hydroxytyrosol, Tyrosol, and Acetylated Derivatives. JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY 2019; 67:7281-7288. [PMID: 31198027 DOI: 10.1021/acs.jafc.9b01065] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/09/2023]
Abstract
Potential metabolites of bioactive compounds are important for their biological activities and as authentic standards for metabolic studies. The phenolic compounds contained in olive oil are an important part of the human diet, and therefore their potential metabolites are of utmost interest. We developed a convenient, scalable, one-pot chemoenzymatic method using the arylsulfotransferase from Desulfitobacterium hafniense for the sulfation of the natural olive oil phenols tyrosol, hydroxytyrosol, and of their monoacetylated derivatives. Respective monosulfated (tentative) metabolites were fully structurally characterized using LC-MS, NMR, and HRMS. In addition, Folin-Ciocalteu reduction, 1,1-diphenyl-2-picrylhydrazyl radical scavenging, and antilipoperoxidant activity in rat liver microsomes damaged by tert-butylhydroperoxide were measured and compared to the parent compounds. As expected, the sulfation diminished the radical scavenging properties of the prepared compounds. These compounds will serve as authentic standards of phase II metabolites.
Collapse
Affiliation(s)
- Paloma Begines
- Department of Organic Chemistry, Faculty of Chemistry , University of Seville , Sevilla E-41012 , Spain
| | - David Biedermann
- Institute of Microbiology , Czech Academy of Sciences , Vídeňská 1083 , Prague CZ 142 20 , Czech Republic
| | - Kateřina Valentová
- Institute of Microbiology , Czech Academy of Sciences , Vídeňská 1083 , Prague CZ 142 20 , Czech Republic
| | - Lucie Petrásková
- Institute of Microbiology , Czech Academy of Sciences , Vídeňská 1083 , Prague CZ 142 20 , Czech Republic
| | - Helena Pelantová
- Institute of Microbiology , Czech Academy of Sciences , Vídeňská 1083 , Prague CZ 142 20 , Czech Republic
| | - Inés Maya
- Department of Organic Chemistry, Faculty of Chemistry , University of Seville , Sevilla E-41012 , Spain
| | - José G Fernández-Bolaños
- Department of Organic Chemistry, Faculty of Chemistry , University of Seville , Sevilla E-41012 , Spain
| | - Vladimír Křen
- Institute of Microbiology , Czech Academy of Sciences , Vídeňská 1083 , Prague CZ 142 20 , Czech Republic
| |
Collapse
|
20
|
Vázquez-Fresno R, Rosana ARR, Sajed T, Onookome-Okome T, Wishart NA, Wishart DS. Herbs and Spices- Biomarkers of Intake Based on Human Intervention Studies - A Systematic Review. GENES AND NUTRITION 2019; 14:18. [PMID: 31143299 PMCID: PMC6532192 DOI: 10.1186/s12263-019-0636-8] [Citation(s) in RCA: 60] [Impact Index Per Article: 10.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 11/09/2018] [Accepted: 04/09/2019] [Indexed: 12/11/2022]
Abstract
Culinary herbs and spices have been used as both food flavoring and food preservative agents for centuries. Moreover, due to their known and presumptive health benefits, herbs and spices have also been used in medical practices since ancient times. Some of the health effects attributed to herbs and spices include antioxidant, anti-microbial, and anti-inflammatory effects as well as potential protection against cardiovascular disease, neurodegeneration, type 2 diabetes, and cancer. While interest in herbs and spices as medicinal agents remains high and their use in foods continues to grow, there have been remarkably few studies that have attempted to track the dietary intake of herbs and spices and even fewer that have tried to find potential biomarkers of food intake (BFIs). The aim of the present review is to systematically survey the global literature on herbs and spices in an effort to identify and evaluate specific intake biomarkers for a representative set of common herbs and spices in humans. A total of 25 herbs and spices were initially chosen, including anise, basil, black pepper, caraway, chili pepper, cinnamon, clove, cumin, curcumin, dill, fennel, fenugreek, ginger, lemongrass, marjoram, nutmeg, oregano, parsley, peppermint and spearmint, rosemary, saffron, sage, tarragon, and thyme. However, only 17 of these herbs and spices had published, peer-reviewed studies describing potential biomarkers of intake. In many studies, the herb or spice of interest was administrated in the form of a capsule or extract and very few studies were performed with actual foods. A systematic assessment of the candidate biomarkers was also performed. Given the limitations in the experimental designs for many of the published studies, further work is needed to better evaluate the identified set of BFIs. Although the daily intake of herbs and spices is very low compared to most other foods, this important set of food seasoning agents should not be underestimated, especially given their potential benefits to human health.
Collapse
Affiliation(s)
- Rosa Vázquez-Fresno
- 1Department of Biological Sciences, University of Alberta, Edmonton, AB T6G 2E9 Canada
| | - Albert Remus R Rosana
- 1Department of Biological Sciences, University of Alberta, Edmonton, AB T6G 2E9 Canada
| | - Tanvir Sajed
- 2Department of Computing Science, University of Alberta, Edmonton, AB T6G 2E8 Canada
| | | | - Noah A Wishart
- 1Department of Biological Sciences, University of Alberta, Edmonton, AB T6G 2E9 Canada
| | - David S Wishart
- 1Department of Biological Sciences, University of Alberta, Edmonton, AB T6G 2E9 Canada.,2Department of Computing Science, University of Alberta, Edmonton, AB T6G 2E8 Canada
| |
Collapse
|
21
|
Yuste S, Ludwig IA, Rubió L, Romero MP, Pedret A, Valls RM, Solà R, Motilva MJ, Macià A. In vivo biotransformation of (poly)phenols and anthocyanins of red-fleshed apple and identification of intake biomarkers. J Funct Foods 2019. [DOI: 10.1016/j.jff.2019.02.013] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/29/2022] Open
|
22
|
Garcia-Aloy M, Hulshof PJM, Estruel-Amades S, Osté MCJ, Lankinen M, Geleijnse JM, de Goede J, Ulaszewska M, Mattivi F, Bakker SJL, Schwab U, Andres-Lacueva C. Biomarkers of food intake for nuts and vegetable oils: an extensive literature search. GENES & NUTRITION 2019; 14:7. [PMID: 30923582 PMCID: PMC6423890 DOI: 10.1186/s12263-019-0628-8] [Citation(s) in RCA: 46] [Impact Index Per Article: 7.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 10/29/2018] [Accepted: 01/25/2019] [Indexed: 01/09/2023]
Abstract
Nuts and vegetable oils are important sources of fat and of a wide variety of micronutrients and phytochemicals. Following their intake, several of their constituents, as well as their derived metabolites, are found in blood circulation and in urine. As a consequence, these could be used to assess the compliance to a dietary intervention or to determine habitual intake of nuts and vegetable oils. However, before these metabolites can be widely used as biomarkers of food intake (BFIs), several characteristics have to be considered, including specificity, dose response, time response, stability, and analytical performance. We have, therefore, conducted an extensive literature search to evaluate current knowledge about potential BFIs of nuts and vegetable oils. Once identified, the strengths and weaknesses of the most promising candidate BFIs have been summarized. Results from selected studies have provided a variety of compounds mainly derived from the fatty fraction of these foods, but also other components and derived metabolites related to their nutritional composition. In particular, α-linolenic acid, urolithins, and 5-hydroxyindole-3-acetic acid seem to be the most plausible candidate BFIs for walnuts, whereas for almonds they could be α-tocopherol and some catechin-derived metabolites. Similarly, several studies have reported a strong association between selenium levels and consumption of Brazil nuts. Intake of vegetable oils has been mainly assessed through the measurement of specific fatty acids in different blood fractions, such as oleic acid for olive oil, α-linolenic acid for flaxseed (linseed) and rapeseed (canola) oils, and linoleic acid for sunflower oil. Additionally, hydroxytyrosol and its metabolites were the most promising distinctive BFIs for (extra) virgin olive oil. However, most of these components lack sufficient specificity to serve as BFIs. Therefore, additional studies are necessary to discover new candidate BFIs, as well as to further evaluate the specificity, sensitivity, dose-response relationships, and reproducibility of these candidate biomarkers and to eventually validate them in other populations. For the discovery of new candidate BFIs, an untargeted metabolomics approach may be the most effective strategy, whereas for increasing the specificity of the evaluation of food consumption, this could be a combination of different metabolites.
Collapse
Affiliation(s)
- Mar Garcia-Aloy
- Biomarkers and Nutrimetabolomics Laboratory, Department of Nutrition, Food Sciences and Gastronomy, XaRTA, INSA, Faculty of Pharmacy and Food Sciences, Campus Torribera, University of Barcelona, Barcelona, Spain
- CIBER de Fragilidad y Envejecimiento Saludable (CIBERFES), Instituto de Salud Carlos III, Barcelona, Spain
| | - Paul J. M. Hulshof
- Division of Human Nutrition and Health, Wageningen University, Wageningen, the Netherlands
| | - Sheila Estruel-Amades
- Biomarkers and Nutrimetabolomics Laboratory, Department of Nutrition, Food Sciences and Gastronomy, XaRTA, INSA, Faculty of Pharmacy and Food Sciences, Campus Torribera, University of Barcelona, Barcelona, Spain
| | - Maryse C. J. Osté
- Department of Internal Medicine, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands
| | - Maria Lankinen
- School of Medicine, Institute of Public Health and Clinical Nutrition, University of Eastern Finland, Kuopio, Finland
| | - Johanna M. Geleijnse
- Division of Human Nutrition and Health, Wageningen University, Wageningen, the Netherlands
| | - Janette de Goede
- Division of Human Nutrition and Health, Wageningen University, Wageningen, the Netherlands
| | - Marynka Ulaszewska
- Department of Food Quality and Nutrition, Research Innovation Center, Fondazione Edmund Mach, Via Mach 1, 38010 San Michele all’Adige, TN Italy
| | - Fulvio Mattivi
- Department of Food Quality and Nutrition, Research Innovation Center, Fondazione Edmund Mach, Via Mach 1, 38010 San Michele all’Adige, TN Italy
- Center Agriculture Food Environment, University of Trento, San Michele all’Adige, Italy
| | - Stephan J. L. Bakker
- Department of Internal Medicine, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands
| | - Ursula Schwab
- School of Medicine, Institute of Public Health and Clinical Nutrition, University of Eastern Finland, Kuopio, Finland
- Department of Medicine, Endocrinology and Clinical Nutrition, Kuopio University Hospital, Kuopio, Finland
| | - Cristina Andres-Lacueva
- Biomarkers and Nutrimetabolomics Laboratory, Department of Nutrition, Food Sciences and Gastronomy, XaRTA, INSA, Faculty of Pharmacy and Food Sciences, Campus Torribera, University of Barcelona, Barcelona, Spain
- CIBER de Fragilidad y Envejecimiento Saludable (CIBERFES), Instituto de Salud Carlos III, Barcelona, Spain
| |
Collapse
|
23
|
Pedret A, Fernández-Castillejo S, Valls RM, Catalán Ú, Rubió L, Romeu M, Macià A, López de Las Hazas MC, Farràs M, Giralt M, Mosele JI, Martín-Peláez S, Remaley AT, Covas MI, Fitó M, Motilva MJ, Solà R. Cardiovascular Benefits of Phenol-Enriched Virgin Olive Oils: New Insights from the Virgin Olive Oil and HDL Functionality (VOHF) Study. Mol Nutr Food Res 2018; 62:e1800456. [PMID: 29956886 PMCID: PMC8456742 DOI: 10.1002/mnfr.201800456] [Citation(s) in RCA: 26] [Impact Index Per Article: 3.7] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/09/2018] [Indexed: 01/09/2023]
Abstract
SCOPE The main findings of the "Virgin Olive Oil and HDL Functionality" (VOHF) study and other related studies on the effect of phenol-enriched virgin olive oil (VOO) supplementation on cardiovascular disease are integrated in the present work. METHODS AND RESULTS VOHF assessed whether VOOs, enriched with their own phenolic compounds (FVOO) or with those from thyme (FVOOT), improve quantity and functionality of HDL. In this randomized, double-blind, crossover, and controlled trial, 33 hypercholesterolemic subjects received a control VOO (80 mg kg-1 ), FVOO (500 mg kg-1 ), and FVOOT (500 mg kg-1 ; 1:1) for 3 weeks. Both functional VOOs promoted cardioprotective changes, modulating HDL proteome, increasing fat-soluble antioxidants, improving HDL subclasses distribution, reducing the lipoprotein insulin resistance index, increasing endogenous antioxidant enzymes, protecting DNA from oxidation, ameliorating endothelial function, and increasing fecal microbial metabolic activity. Additional cardioprotective benefits were observed according to phenol source and content in the phenol-enriched VOOs. These insights support the beneficial effects of OO and PC from different sources. CONCLUSION Novel therapeutic strategies should increase HDL-cholesterol levels and enhance HDL functionality. The tailoring of phenol-enriched VOOs is an interesting and useful strategy for enhancing the functional quality of HDL, and thus, it can be used as a complementary tool for the management of hypercholesterolemic individuals.
Collapse
Affiliation(s)
- Anna Pedret
- Eurecat, Centre Tecnològic de Catalunya, Unitat de Nutrició i Salut, Functional Nutrition, Oxidation, and CVD Research Group (NFOC-Salut), 43204, Reus, Spain
- Facultat de Medicina i Ciències de la Salut, Functional Nutrition, Oxidation and Cardiovascular Diseases Group (NFOC-Salut), Universitat Rovira i Virgili, 43201, Reus, Spain
| | - Sara Fernández-Castillejo
- Facultat de Medicina i Ciències de la Salut, Functional Nutrition, Oxidation and Cardiovascular Diseases Group (NFOC-Salut), Universitat Rovira i Virgili, 43201, Reus, Spain
- Institut d'Investigació Sanitaria Pere Virgili, 43204, Reus, Spain
| | - Rosa-Maria Valls
- Facultat de Medicina i Ciències de la Salut, Functional Nutrition, Oxidation and Cardiovascular Diseases Group (NFOC-Salut), Universitat Rovira i Virgili, 43201, Reus, Spain
| | - Úrsula Catalán
- Facultat de Medicina i Ciències de la Salut, Functional Nutrition, Oxidation and Cardiovascular Diseases Group (NFOC-Salut), Universitat Rovira i Virgili, 43201, Reus, Spain
- Institut d'Investigació Sanitaria Pere Virgili, 43204, Reus, Spain
| | - Laura Rubió
- Facultat de Medicina i Ciències de la Salut, Functional Nutrition, Oxidation and Cardiovascular Diseases Group (NFOC-Salut), Universitat Rovira i Virgili, 43201, Reus, Spain
- Antioxidants Research Group, Food Technology Department, Universitat de Lleida-Agrotecnio Center, 25198, Lleida, Spain
| | - Marta Romeu
- Facultat de Medicina i Ciències de la Salut, Functional Nutrition, Oxidation and Cardiovascular Diseases Group (NFOC-Salut), Universitat Rovira i Virgili, 43201, Reus, Spain
| | - Alba Macià
- Antioxidants Research Group, Food Technology Department, Universitat de Lleida-Agrotecnio Center, 25198, Lleida, Spain
| | - Maria Carmen López de Las Hazas
- Antioxidants Research Group, Food Technology Department, Universitat de Lleida-Agrotecnio Center, 25198, Lleida, Spain
- Laboratory of Epigenetics of Lipid Metabolism, Instituto Madrileño de Estudios Avanzados-Alimentación, CEI UAM+CSIC, 28049, Madrid, Spain
| | - Marta Farràs
- Institut d'Investigacions Biomèdiques (IIB) Sant Pau, 08025, Barcelona, Spain
- Cardiovascular Risk and Nutrition Research Group, REGICOR Study Group, Hospital del Mar Research Institute (IMIM), 08003, Barcelona, Spain
| | - Montse Giralt
- Facultat de Medicina i Ciències de la Salut, Functional Nutrition, Oxidation and Cardiovascular Diseases Group (NFOC-Salut), Universitat Rovira i Virgili, 43201, Reus, Spain
| | - Juana I Mosele
- Antioxidants Research Group, Food Technology Department, Universitat de Lleida-Agrotecnio Center, 25198, Lleida, Spain
- Instituto de Bioquímica y Medicina Molecular (IBIMOL), CONICET - Universidad de Buenos Aires, 1053, Buenos Aires, Argentina
- Facultad de Farmacia y Bioquímica, Departamento de Química Analítica y Fisicoquímica, Cátedra de Fisicoquímica, Universidad de Buenos Aires, C1113AAD, Buenos Aires, Argentina
| | - Sandra Martín-Peláez
- Spanish Biomedical Research Networking Centre (CIBER), Physiopathology of Obesity and Nutrition (CIBEROBN), Institute of Health Carlos III, 28029, Madrid, Spain
- Cardiovascular Risk and Nutrition Research Group, REGICOR Study Group, Hospital del Mar Research Institute (IMIM), 08003, Barcelona, Spain
| | - Alan T Remaley
- Department of Laboratory Medicine Clinical Center, National Institutes of Health, 20814, Bethesda, MD, USA
- Lipoprotein Metabolism Section Cardio-Pulmonary Branch National Heart, Lung and Blood Institute National Institutes of Health, 20814, Bethesda, MD, USA
| | - Maria-Isabel Covas
- Spanish Biomedical Research Networking Centre (CIBER), Physiopathology of Obesity and Nutrition (CIBEROBN), Institute of Health Carlos III, 28029, Madrid, Spain
- Cardiovascular Risk and Nutrition Research Group, REGICOR Study Group, Hospital del Mar Research Institute (IMIM), 08003, Barcelona, Spain
- NUPROAS (Nutritional Project Assessment), Handesbolag (NUPROAS HB), 13100, Nacka, Sweden
| | - Montse Fitó
- Spanish Biomedical Research Networking Centre (CIBER), Physiopathology of Obesity and Nutrition (CIBEROBN), Institute of Health Carlos III, 28029, Madrid, Spain
- Cardiovascular Risk and Nutrition Research Group, REGICOR Study Group, Hospital del Mar Research Institute (IMIM), 08003, Barcelona, Spain
| | - Maria-José Motilva
- Antioxidants Research Group, Food Technology Department, Universitat de Lleida-Agrotecnio Center, 25198, Lleida, Spain
| | - Rosa Solà
- Facultat de Medicina i Ciències de la Salut, Functional Nutrition, Oxidation and Cardiovascular Diseases Group (NFOC-Salut), Universitat Rovira i Virgili, 43201, Reus, Spain
- Institut d'Investigació Sanitaria Pere Virgili, 43204, Reus, Spain
- Hospital Universitari Sant Joan de Reus, 43204, Reus, Spain
| |
Collapse
|
24
|
López de las Hazas MC, Godinho-Pereira J, Macià A, Almeida AF, Ventura MR, Motilva MJ, Santos CN. Brain uptake of hydroxytyrosol and its main circulating metabolites: Protective potential in neuronal cells. J Funct Foods 2018. [DOI: 10.1016/j.jff.2018.04.028] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/12/2022] Open
|
25
|
Farràs M, Fernández-Castillejo S, Rubió L, Arranz S, Catalán Ú, Subirana I, Romero MP, Castañer O, Pedret A, Blanchart G, Muñoz-Aguayo D, Schröder H, Covas MI, de la Torre R, Motilva MJ, Solà R, Fitó M. Phenol-enriched olive oils improve HDL antioxidant content in hypercholesterolemic subjects. A randomized, double-blind, cross-over, controlled trial. J Nutr Biochem 2018; 51:99-104. [PMID: 29125992 DOI: 10.1016/j.jnutbio.2017.09.010] [Citation(s) in RCA: 23] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/03/2016] [Revised: 08/22/2017] [Accepted: 09/11/2017] [Indexed: 11/23/2022]
Abstract
At present, high-density lipoprotein (HDL) function is thought to be more relevant than HDL cholesterol quantity. Consumption of olive oil phenolic compounds (PCs) has beneficial effects on HDL-related markers. Enriched food with complementary antioxidants could be a suitable option to obtain additional protective effects. Our aim was to ascertain whether virgin olive oils (VOOs) enriched with (a) their own PC (FVOO) and (b) their own PC plus complementary ones from thyme (FVOOT) could improve HDL status and function. Thirty-three hypercholesterolemic individuals ingested (25 ml/day, 3 weeks) (a) VOO (80 ppm), (b) FVOO (500 ppm) and (c) FVOOT (500 ppm) in a randomized, double-blind, controlled, crossover trial. A rise in HDL antioxidant compounds was observed after both functional olive oil interventions. Nevertheless, α-tocopherol, the main HDL antioxidant, was only augmented after FVOOT versus its baseline. In conclusion, long-term consumption of phenol-enriched olive oils induced a better HDL antioxidant content, the complementary phenol-enriched olive oil being the one which increased the main HDL antioxidant, α-tocopherol. Complementary phenol-enriched olive oil could be a useful dietary tool for improving HDL richness in antioxidants.
Collapse
Affiliation(s)
- Marta Farràs
- Cardiovascular Risk and Nutrition Research Group, Regicor Study Group. IMIM (Hospital del Mar Medical Research Institute), Doctor Aiguader 88, 08003 Barcelona, Spain; CIBER de Fisiopatología de la Obesidad y la Nutrición (CIBEROBN); Ph.D. Program in Biochemistry, Molecular Biology and Biomedicine, Department of Biochemistry and Molecular Biology, Universitat Autònoma de Barcelona (UAB), Barcelona, Spain
| | - Sara Fernández-Castillejo
- Research Unit on Lipids and Atherosclerosis, St. Joan de Reus University Hospital, Institut d'Investigació Sanitària Pere Virgili (IISPV), Functional Nutrition, Oxidation, and Cardiovascular Disease (NFOC-SALUT) group, Universitat Rovira i Virgili, Sant Llorenç 21, 43201 Reus, Spain
| | - Laura Rubió
- Research Unit on Lipids and Atherosclerosis, St. Joan de Reus University Hospital, Institut d'Investigació Sanitària Pere Virgili (IISPV), Functional Nutrition, Oxidation, and Cardiovascular Disease (NFOC-SALUT) group, Universitat Rovira i Virgili, Sant Llorenç 21, 43201 Reus, Spain; Food Technology Department, UTPV-XaRTA, Agrotecnio Center, University of Lleida, Alcalde Rovira Roure 191, 25198 Lleida, Spain
| | - Sara Arranz
- Cardiovascular Risk and Nutrition Research Group, Regicor Study Group. IMIM (Hospital del Mar Medical Research Institute), Doctor Aiguader 88, 08003 Barcelona, Spain
| | - Úrsula Catalán
- Research Unit on Lipids and Atherosclerosis, St. Joan de Reus University Hospital, Institut d'Investigació Sanitària Pere Virgili (IISPV), Functional Nutrition, Oxidation, and Cardiovascular Disease (NFOC-SALUT) group, Universitat Rovira i Virgili, Sant Llorenç 21, 43201 Reus, Spain
| | - Isaac Subirana
- CIBER de Epidemiología y Salud Pública (CIBERESP); Cardiovascular Epidemiology and Genetics Research Group, Regicor Study Group. IMIM (Hospital del Mar Medical Research Institute), Doctor Aiguader 88, 08003 Barcelona, Spain
| | - Mari-Paz Romero
- Food Technology Department, UTPV-XaRTA, Agrotecnio Center, University of Lleida, Alcalde Rovira Roure 191, 25198 Lleida, Spain
| | - Olga Castañer
- Cardiovascular Risk and Nutrition Research Group, Regicor Study Group. IMIM (Hospital del Mar Medical Research Institute), Doctor Aiguader 88, 08003 Barcelona, Spain; CIBER de Fisiopatología de la Obesidad y la Nutrición (CIBEROBN)
| | - Anna Pedret
- Research Unit on Lipids and Atherosclerosis, St. Joan de Reus University Hospital, Institut d'Investigació Sanitària Pere Virgili (IISPV), Functional Nutrition, Oxidation, and Cardiovascular Disease (NFOC-SALUT) group, Universitat Rovira i Virgili, Sant Llorenç 21, 43201 Reus, Spain; Eurecat-Centre Tecnològic de Nutrició i Salut (Eurecat-CTNS), Reus, Spain
| | - Gemma Blanchart
- Cardiovascular Epidemiology and Genetics Research Group, Regicor Study Group. IMIM (Hospital del Mar Medical Research Institute), Doctor Aiguader 88, 08003 Barcelona, Spain
| | - Daniel Muñoz-Aguayo
- Cardiovascular Risk and Nutrition Research Group, Regicor Study Group. IMIM (Hospital del Mar Medical Research Institute), Doctor Aiguader 88, 08003 Barcelona, Spain; CIBER de Fisiopatología de la Obesidad y la Nutrición (CIBEROBN)
| | - Helmut Schröder
- Cardiovascular Risk and Nutrition Research Group, Regicor Study Group. IMIM (Hospital del Mar Medical Research Institute), Doctor Aiguader 88, 08003 Barcelona, Spain; CIBER de Epidemiología y Salud Pública (CIBERESP)
| | - Maria-Isabel Covas
- Cardiovascular Risk and Nutrition Research Group, Regicor Study Group. IMIM (Hospital del Mar Medical Research Institute), Doctor Aiguader 88, 08003 Barcelona, Spain; CIBER de Fisiopatología de la Obesidad y la Nutrición (CIBEROBN); NUPROAS Handelsbolag, Nacka, Sweden
| | - Rafael de la Torre
- CIBER de Fisiopatología de la Obesidad y la Nutrición (CIBEROBN); Integrative Pharmacology and Systems Neuroscience Research Group, IMIM (Hospital del Mar Medical Research Institute), Doctor Aiguader 88, 08003 Barcelona, Spain; Universitat Pompeu Fabra (CEXS-UPF), Doctor Aiguader 80, 08003 Barcelona, Spain
| | - Maria-José Motilva
- Food Technology Department, UTPV-XaRTA, Agrotecnio Center, University of Lleida, Alcalde Rovira Roure 191, 25198 Lleida, Spain
| | - Rosa Solà
- Research Unit on Lipids and Atherosclerosis, St. Joan de Reus University Hospital, Institut d'Investigació Sanitària Pere Virgili (IISPV), Functional Nutrition, Oxidation, and Cardiovascular Disease (NFOC-SALUT) group, Universitat Rovira i Virgili, Sant Llorenç 21, 43201 Reus, Spain
| | - Montserrat Fitó
- Cardiovascular Risk and Nutrition Research Group, Regicor Study Group. IMIM (Hospital del Mar Medical Research Institute), Doctor Aiguader 88, 08003 Barcelona, Spain; CIBER de Fisiopatología de la Obesidad y la Nutrición (CIBEROBN).
| |
Collapse
|
26
|
Peyrol J, Meyer G, Obert P, Dangles O, Pechère L, Amiot MJ, Riva C. Involvement of bilitranslocase and beta-glucuronidase in the vascular protection by hydroxytyrosol and its glucuronide metabolites in oxidative stress conditions. J Nutr Biochem 2018; 51:8-15. [DOI: 10.1016/j.jnutbio.2017.09.009] [Citation(s) in RCA: 16] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/18/2017] [Revised: 09/11/2017] [Accepted: 09/11/2017] [Indexed: 11/26/2022]
|
27
|
Catalán Ú, López de las Hazas MC, Piñol C, Rubió L, Motilva MJ, Fernandez-Castillejo S, Solà R. Hydroxytyrosol and its main plasma circulating metabolites attenuate the initial steps of atherosclerosis through inhibition of the MAPK pathway. J Funct Foods 2018. [DOI: 10.1016/j.jff.2017.11.007] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/15/2022] Open
|
28
|
Robles-Almazan M, Pulido-Moran M, Moreno-Fernandez J, Ramirez-Tortosa C, Rodriguez-Garcia C, Quiles JL, Ramirez-Tortosa MC. Hydroxytyrosol: Bioavailability, toxicity, and clinical applications. Food Res Int 2017; 105:654-667. [PMID: 29433260 DOI: 10.1016/j.foodres.2017.11.053] [Citation(s) in RCA: 194] [Impact Index Per Article: 24.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/04/2017] [Revised: 11/12/2017] [Accepted: 11/19/2017] [Indexed: 12/12/2022]
Abstract
Many beneficial properties have been attributed to the Mediterranean diet. Over the years, researchers have attempted to learn which foods and which food components are responsible for good health. One of these components is hydroxytyrosol, an important phenolic compound present in olive oil. Hydroxytyrosol is a molecule of high interest to the pharmaceutical industry due to its anti-inflammatory and antimicrobial qualities its role against cardiovascular diseases and metabolic syndrome and for its neuroprotection, antitumour, and chemo modulation effects. The interest in this molecule has led to wide research on its biological activities, its beneficial effects in humans and how to synthetize new molecules from hydroxytyrosol. This review describes the vast range of information about hydroxytyrosol, focusing on its involvement in biological mechanisms and modulation effects on different pathologies. This review also serves to highlight the role of hydroxytyrosol as a nutraceutical and as a potential therapeutic agent.
Collapse
Affiliation(s)
- María Robles-Almazan
- Department of Pathological Anatomy, Hospital Complex of Jaén, Avenida del Ejército Español, 10, Jaén 23007, Spain
| | - Mario Pulido-Moran
- Department of Biochemistry and Molecular Biology II, Faculty of Pharmacy, University of Granada, University campus of Cartuja, Granada 18071, Spain; Institute of Nutrition and Food Technology José Mataix, University of Granada, Biomedical Research Centre, Avenida del Conocimiento, Armilla, Granada 18016, Spain
| | - Jorge Moreno-Fernandez
- Department of Physiology, Faculty of Pharmacy, University of Granada, University campus of Cartuja, Granada 18071, Spain; Institute of Nutrition and Food Technology José Mataix, University of Granada, Biomedical Research Centre, Avenida del Conocimiento, Armilla, Granada 18016, Spain
| | - Cesar Ramirez-Tortosa
- Department of Pathological Anatomy, Hospital Complex of Jaén, Avenida del Ejército Español, 10, Jaén 23007, Spain
| | - Carmen Rodriguez-Garcia
- Department of Biochemistry and Molecular Biology II, Faculty of Pharmacy, University of Granada, University campus of Cartuja, Granada 18071, Spain; Institute of Nutrition and Food Technology José Mataix, University of Granada, Biomedical Research Centre, Avenida del Conocimiento, Armilla, Granada 18016, Spain
| | - Jose L Quiles
- Department of Physiology, Faculty of Pharmacy, University of Granada, University campus of Cartuja, Granada 18071, Spain; Institute of Nutrition and Food Technology José Mataix, University of Granada, Biomedical Research Centre, Avenida del Conocimiento, Armilla, Granada 18016, Spain
| | - MCarmen Ramirez-Tortosa
- Department of Biochemistry and Molecular Biology II, Faculty of Pharmacy, University of Granada, University campus of Cartuja, Granada 18071, Spain; Institute of Nutrition and Food Technology José Mataix, University of Granada, Biomedical Research Centre, Avenida del Conocimiento, Armilla, Granada 18016, Spain.
| |
Collapse
|
29
|
Fernández-Castillejo S, García-Heredia AI, Solà R, Camps J, López de la Hazas MC, Farràs M, Pedret A, Catalán Ú, Rubió L, Motilva MJ, Castañer O, Covas MI, Valls RM. Phenol-enriched olive oils modify paraoxonase-related variables: A randomized, crossover, controlled trial. Mol Nutr Food Res 2017; 61. [PMID: 28544610 DOI: 10.1002/mnfr.201600932] [Citation(s) in RCA: 16] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/21/2016] [Revised: 04/20/2017] [Accepted: 04/21/2017] [Indexed: 12/18/2022]
Abstract
SCOPE Low paraoxonase (PON)1 activities, and high PON1 and low PON3 protein levels are characteristic of cardiovascular disease. Our aim was to assess short- and long-term effects of virgin olive oils (VOO), enriched with their own phenolic compounds (PC; FVOO) or with them plus complementary PC from thyme (FVOOT), on PON-related variables and the mechanisms involved. METHODS AND RESULTS Two randomized, controlled, double-blind, and crossover interventions were conducted. In an acute intake study, participants ingested three FVOOs differing in PC content. In a sustained intake study, participants ingested a control VOO and two different FVOOs with the same PC content but differing in PC source. Acute and sustained intake of VOO and FVOO decreased PON1 protein and increased PON1-associated specific activities, while FVOOT yielded opposite results. PON3 protein levels increased only after sustained consumption of VOO. Mechanistic studies performed in rat livers showed that intake of isolated PC from VOO and from thyme modulate mitogen-activated protein kinases and peroxisome proliferator-activated receptors regulating PON synthesis, while a combination of these PCs cancels such regulation. CONCLUSION This study reveals that the intake of phenol-enriched FVOOs modulates oxidative balance by modifying PON-related variables according to PC content and source, and this modulation can be perceived as beneficial.
Collapse
Affiliation(s)
- Sara Fernández-Castillejo
- Research Unit on Lipids and Atherosclerosis, Hospital Universitari Sant Joan, Institut d'Investigació Sanitària Pere Virgili (IISPV), Functional Nutrition, Oxidation and Cardiovascular Disease (NFOC-SALUT) group, Universitat Rovira i Virgili, Reus, Spain.,CIBER de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Instituto de Salud Carlos III, Madrid, Spain
| | - Ana-Isabel García-Heredia
- Unitat de Recerca Biomèdica, Hospital Universitari Sant Joan, IISPV, Universitat Rovira i Virgili, Reus, Spain
| | - Rosa Solà
- Research Unit on Lipids and Atherosclerosis, Hospital Universitari Sant Joan, Institut d'Investigació Sanitària Pere Virgili (IISPV), Functional Nutrition, Oxidation and Cardiovascular Disease (NFOC-SALUT) group, Universitat Rovira i Virgili, Reus, Spain.,CIBER de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Instituto de Salud Carlos III, Madrid, Spain
| | - Jordi Camps
- Unitat de Recerca Biomèdica, Hospital Universitari Sant Joan, IISPV, Universitat Rovira i Virgili, Reus, Spain
| | | | - Marta Farràs
- Division of Computational and Systems Medicine, Department of Surgery and Cancer, Imperial College London, London, UK.,Cardiovascular Risk and Nutrition Research group, IMIM- Institut Hospital del Mar d'Investigacions Mèdiques, Barcelona, Spain.,CIBER de Fisiopatología de la Obesidad y la Nutrición (CIBEROBN), Instituto de Salud Carlos III, Madrid, Spain
| | - Anna Pedret
- Research Unit on Lipids and Atherosclerosis, Hospital Universitari Sant Joan, Institut d'Investigació Sanitària Pere Virgili (IISPV), Functional Nutrition, Oxidation and Cardiovascular Disease (NFOC-SALUT) group, Universitat Rovira i Virgili, Reus, Spain.,CIBER de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Instituto de Salud Carlos III, Madrid, Spain
| | - Úrsula Catalán
- Research Unit on Lipids and Atherosclerosis, Hospital Universitari Sant Joan, Institut d'Investigació Sanitària Pere Virgili (IISPV), Functional Nutrition, Oxidation and Cardiovascular Disease (NFOC-SALUT) group, Universitat Rovira i Virgili, Reus, Spain.,CIBER de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Instituto de Salud Carlos III, Madrid, Spain
| | - Laura Rubió
- Research Unit on Lipids and Atherosclerosis, Hospital Universitari Sant Joan, Institut d'Investigació Sanitària Pere Virgili (IISPV), Functional Nutrition, Oxidation and Cardiovascular Disease (NFOC-SALUT) group, Universitat Rovira i Virgili, Reus, Spain.,CIBER de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Instituto de Salud Carlos III, Madrid, Spain.,Department of Food Technology, Agrotecnio Center, University of Lleida, Lleida, Spain
| | - Maria-José Motilva
- Department of Food Technology, Agrotecnio Center, University of Lleida, Lleida, Spain
| | - Olga Castañer
- Cardiovascular Risk and Nutrition Research group, IMIM- Institut Hospital del Mar d'Investigacions Mèdiques, Barcelona, Spain.,CIBER de Fisiopatología de la Obesidad y la Nutrición (CIBEROBN), Instituto de Salud Carlos III, Madrid, Spain
| | - María-Isabel Covas
- Cardiovascular Risk and Nutrition Research group, IMIM- Institut Hospital del Mar d'Investigacions Mèdiques, Barcelona, Spain.,CIBER de Fisiopatología de la Obesidad y la Nutrición (CIBEROBN), Instituto de Salud Carlos III, Madrid, Spain.,NUPROAS (Nutritional Project Assessment), Handesbolag (NUPROAS HB), Nacka, Sweden
| | - Rosa-Maria Valls
- Research Unit on Lipids and Atherosclerosis, Hospital Universitari Sant Joan, Institut d'Investigació Sanitària Pere Virgili (IISPV), Functional Nutrition, Oxidation and Cardiovascular Disease (NFOC-SALUT) group, Universitat Rovira i Virgili, Reus, Spain.,CIBER de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Instituto de Salud Carlos III, Madrid, Spain
| |
Collapse
|
30
|
Valls RM, Farràs M, Pedret A, Fernández-Castillejo S, Catalán Ú, Romeu M, Giralt M, Sáez GT, Fitó M, de la Torre R, Covas MI, Motilva MJ, Solà R, Rubió L. Virgin olive oil enriched with its own phenolic compounds or complemented with thyme improves endothelial function: The potential role of plasmatic fat-soluble vitamins. A double blind, randomized, controlled, cross-over clinical trial. J Funct Foods 2017. [DOI: 10.1016/j.jff.2016.10.032] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/02/2023] Open
|
31
|
Perez-Ternero C, Macià A, de Sotomayor MA, Parrado J, Motilva MJ, Herrera MD. Bioavailability of the ferulic acid-derived phenolic compounds of a rice bran enzymatic extract and their activity against superoxide production. Food Funct 2017; 8:2165-2174. [DOI: 10.1039/c7fo00243b] [Citation(s) in RCA: 18] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/22/2023]
Abstract
Rice bran is an exceptional source of such antioxidant molecules as γ-oryzanol and ferulic acid, but their bioavailability and metabolism within this matrix remain unknown.
Collapse
Affiliation(s)
| | - Alba Macià
- Food Technology Department
- XaRTA-TPV
- Agrotecnio Center
- Escola Tècnica Superior d'Enginyeria Agrària
- University of Lleida
| | | | - Juan Parrado
- Department of Biochemistry
- School of Pharmacy
- University of Seville
- 41012 Seville
- Spain
| | - Maria-Jose Motilva
- Food Technology Department
- XaRTA-TPV
- Agrotecnio Center
- Escola Tècnica Superior d'Enginyeria Agrària
- University of Lleida
| | | |
Collapse
|
32
|
Fernández-Castillejo S, Valls RM, Castañer O, Rubió L, Catalán Ú, Pedret A, Macià A, Sampson ML, Covas MI, Fitó M, Motilva MJ, Remaley AT, Solà R. Polyphenol rich olive oils improve lipoprotein particle atherogenic ratios and subclasses profile: A randomized, crossover, controlled trial. Mol Nutr Food Res 2016; 60:1544-54. [PMID: 26992050 DOI: 10.1002/mnfr.201501068] [Citation(s) in RCA: 37] [Impact Index Per Article: 4.1] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/28/2015] [Revised: 02/12/2016] [Accepted: 02/22/2016] [Indexed: 12/25/2022]
Abstract
SCOPE Lipoprotein particle measures performed by nuclear magnetic resonance (NMR), and associated ratios, may be better markers for atherosclerosis risk than conventional lipid measures. The effect of two functional olive oils, one enriched with its polyphenols (FVOO, 500 ppm), and the other (FVOOT) with them (250 ppm) and those of thyme (250 ppm), versus a standard virgin olive oil (VOO), on lipoprotein particle atherogenic ratios and subclasses profiles was assessed. METHODS AND RESULTS In a randomized, double-blind, crossover, controlled trial, 33 hypercholesterolemic individuals received 25 mL/day of VOO, FVOO, and FVOOT. Intervention periods were of 3 weeks separated by 2-week washout periods. Lipoprotein particle counts and subclasses were measured by NMR. Polyphenols from olive oil and thyme modified the lipoprotein subclasses profile and decreased the total LDL particle/total HDL particle (HDL-P), small HDL/large HDL, and HDL-cholesterol/HDL-P ratios, and decreased the lipoprotein insulin resistance index (LP-IR) (p < 0.05). CONCLUSION Olive oil polyphenols, and those from thyme provided benefits on lipoprotein particle atherogenic ratios and subclasses profile distribution. Polyphenol-enriched olive oil is a way of increasing the olive oil healthy properties while consuming the same amount of fat, as well as a useful and complementary tool for the management of cardiovascular risk individuals.
Collapse
Affiliation(s)
- Sara Fernández-Castillejo
- Research Unit on Lipids and Atherosclerosis, Hospital Universitari Sant Joan, Institut Investigació Sanitària Pere Virgili, NFOC group, Facultat de Medicina i Ciències de la Salut, Universitat Rovira i Virgili, CIBERDEM, Reus, Spain
| | - Rosa-Maria Valls
- Research Unit on Lipids and Atherosclerosis, Hospital Universitari Sant Joan, Institut Investigació Sanitària Pere Virgili, NFOC group, Facultat de Medicina i Ciències de la Salut, Universitat Rovira i Virgili, CIBERDEM, Reus, Spain
| | - Olga Castañer
- Cardiovascular Risk and Nutrition Research group, IMIM- Institut Hospital del Mar d'Investigacions Mèdiques, CIBEROBN, Barcelona, Spain
| | - Laura Rubió
- Research Unit on Lipids and Atherosclerosis, Hospital Universitari Sant Joan, Institut Investigació Sanitària Pere Virgili, NFOC group, Facultat de Medicina i Ciències de la Salut, Universitat Rovira i Virgili, CIBERDEM, Reus, Spain.,Food Technology Department; Agrotecnio Center, University of Lleida, Lleida, Spain
| | - Úrsula Catalán
- Research Unit on Lipids and Atherosclerosis, Hospital Universitari Sant Joan, Institut Investigació Sanitària Pere Virgili, NFOC group, Facultat de Medicina i Ciències de la Salut, Universitat Rovira i Virgili, CIBERDEM, Reus, Spain
| | - Anna Pedret
- Research Unit on Lipids and Atherosclerosis, Hospital Universitari Sant Joan, Institut Investigació Sanitària Pere Virgili, NFOC group, Facultat de Medicina i Ciències de la Salut, Universitat Rovira i Virgili, CIBERDEM, Reus, Spain
| | - Alba Macià
- Food Technology Department; Agrotecnio Center, University of Lleida, Lleida, Spain
| | - Maureen L Sampson
- Department of Laboratory Medicine, Clinical Center, National Institutes of Health, Bethesda, MD, USA
| | - María-Isabel Covas
- Cardiovascular Risk and Nutrition Research group, IMIM- Institut Hospital del Mar d'Investigacions Mèdiques, CIBEROBN, Barcelona, Spain
| | - Montserrat Fitó
- Cardiovascular Risk and Nutrition Research group, IMIM- Institut Hospital del Mar d'Investigacions Mèdiques, CIBEROBN, Barcelona, Spain
| | - Maria-José Motilva
- Food Technology Department; Agrotecnio Center, University of Lleida, Lleida, Spain
| | - Alan T Remaley
- Department of Laboratory Medicine, Clinical Center, National Institutes of Health, Bethesda, MD, USA.,Lipoprotein Metabolism Section, Cardio-Pulmonary Branch, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD, USA
| | - Rosa Solà
- Research Unit on Lipids and Atherosclerosis, Hospital Universitari Sant Joan, Institut Investigació Sanitària Pere Virgili, NFOC group, Facultat de Medicina i Ciències de la Salut, Universitat Rovira i Virgili, CIBERDEM, Reus, Spain
| |
Collapse
|
33
|
|
34
|
Martín-Peláez S, Castañer O, Solà R, Motilva MJ, Castell M, Pérez-Cano FJ, Fitó M. Influence of Phenol-Enriched Olive Oils on Human Intestinal Immune Function. Nutrients 2016; 8:213. [PMID: 27077879 PMCID: PMC4848682 DOI: 10.3390/nu8040213] [Citation(s) in RCA: 39] [Impact Index Per Article: 4.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/25/2016] [Revised: 04/01/2016] [Accepted: 04/05/2016] [Indexed: 12/25/2022] Open
Abstract
Olive oil (OO) phenolic compounds (PC) are able to influence gut microbial populations and metabolic output. Our aim was to investigate whether these compounds and changes affect the mucosal immune system. In a randomized, controlled, double blind cross-over human trial, for three weeks, preceded by two-week washout periods, 10 hypercholesterolemic participants ingested 25 mL/day of three raw virgin OO differing in their PC concentration and origin: (1) an OO containing 80 mg PC/kg (VOO); (2) a PC-enriched OO containing 500 mg PC/kg from OO (FVOO); and (3) a PC-enriched OO containing a mixture of 500 mg PC/kg from OO and thyme (1:1, FVOOT). Intestinal immunity (fecal immunoglobulin A (IgA) and IgA-coated bacteria) and inflammation markers (C-reactive protein (CRP) and fecal interleukin 6 (IL-6), tumor necrosis factor α (TNFα) and calprotectin) was analyzed. The ingestion of high amounts of OO PC, as contained in FVOO, tended to increase the proportions of IgA-coated bacteria and increased plasma levels of CRP. However, lower amounts of OO PC (VOO) and the combination of two PC sources (FVOOT) did not show significant effects on the variables investigated. Results indicate a potential stimulation of the immune system with very high doses of OO PC, which should be further investigated.
Collapse
Affiliation(s)
- Sandra Martín-Peláez
- Cardiovascular Risk and Nutrition Research Group, REGICOR Study Group, Hospital del Mar Research Institute (IMIM), Barcelona 08003, Spain.
- Spanish Biomedical Research Networking Centre (CIBER), Physiopathology of Obesity and Nutrition (CIBEROBN), Institute of Health Carlos III, Madrid 28029, Spain.
| | - Olga Castañer
- Cardiovascular Risk and Nutrition Research Group, REGICOR Study Group, Hospital del Mar Research Institute (IMIM), Barcelona 08003, Spain.
- Spanish Biomedical Research Networking Centre (CIBER), Physiopathology of Obesity and Nutrition (CIBEROBN), Institute of Health Carlos III, Madrid 28029, Spain.
| | - Rosa Solà
- Unit of Farmacobiology, Faculty of Medicine and Health Sciences, University Rovira i Virgili, Reus 43201, Spain.
| | - María José Motilva
- Food Technology Department, UTPV-XaRTA, University of Lleida-Agrotecnio Center, Lleida 25198, Spain.
| | - Margarida Castell
- Department of Physiology, Faculty of Pharmacy, University of Barcelona, Barcelona 08028, Spain.
- Nutrition and Food Safety Research Institute (INSA-UB), Barcelona 08028, Spain.
| | - Francisco José Pérez-Cano
- Department of Physiology, Faculty of Pharmacy, University of Barcelona, Barcelona 08028, Spain.
- Nutrition and Food Safety Research Institute (INSA-UB), Barcelona 08028, Spain.
| | - Montserrat Fitó
- Cardiovascular Risk and Nutrition Research Group, REGICOR Study Group, Hospital del Mar Research Institute (IMIM), Barcelona 08003, Spain.
- Spanish Biomedical Research Networking Centre (CIBER), Physiopathology of Obesity and Nutrition (CIBEROBN), Institute of Health Carlos III, Madrid 28029, Spain.
| |
Collapse
|
35
|
Romeu M, Rubió L, Sánchez-Martos V, Castañer O, de la Torre R, Valls RM, Ras R, Pedret A, Catalán Ú, López de las Hazas MDC, Motilva MJ, Fitó M, Solà R, Giralt M. Virgin Olive Oil Enriched with Its Own Phenols or Complemented with Thyme Phenols Improves DNA Protection against Oxidation and Antioxidant Enzyme Activity in Hyperlipidemic Subjects. JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY 2016; 64:1879-1888. [PMID: 26889783 DOI: 10.1021/acs.jafc.5b04915] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/05/2023]
Abstract
The effects of virgin olive oil (VOO) enriched with its own phenolic compounds (PC) and/or thyme PC on the protection against oxidative DNA damage and antioxidant endogenous enzymatic system (AEES) were estimated in 33 hyperlipidemic subjects after the consumption of VOO, VOO enriched with its own PC (FVOO), or VOO complemented with thyme PC (FVOOT). Compared to pre-intervention, 8-hydroxy-2'-deoxyguanosine (a marker for DNA damage) decreased in the FVOO intervention and to a greater extent in the FVOOT with a parallel significant increase in olive and thyme phenolic metabolites. Superoxide dismutase (AEES enzyme) significantly increased in the FVOO intervention and to a greater extent in the FVOOT with a parallel significant increase in thyme phenolic metabolites. When all three oils were compared, FVOOT appeared to have the greatest effect in protecting against oxidative DNA damage and improving AEES. The sustained intake of a FVOOT improves DNA protection against oxidation and AEES probably due to a greater bioavailability of thyme PC in hyperlipidemic subjects.
Collapse
Affiliation(s)
- Marta Romeu
- Pharmacology Unit, Department of Basic Medical Sciences, Facultat de Medicina i Ciències de la Salut, NFOC group, Universitat Rovira i Virgili , C/Sant Llorenç 21, 43201 Reus, Spain
| | - Laura Rubió
- Food Technology Department, UTPV-XaRTA, Agrotecnio Research Center, Universitat de Lleida , C. Alcalde Rovira Roure 191, 25198 Lleida, Spain
- Unitat de Recerca en Lı́pids i Arteriosclerosis, CIBERDEM, St. Joan de Reus University Hospital, CTNS, IISPV, Facultat de Medicina i Ciències de la Salut, NFOC Group, Universitat Rovira i Virgili , C. Sant Llorenç 21, 43201 Reus, Spain
| | - Vanessa Sánchez-Martos
- Pharmacology Unit, Department of Basic Medical Sciences, Facultat de Medicina i Ciències de la Salut, NFOC group, Universitat Rovira i Virgili , C/Sant Llorenç 21, 43201 Reus, Spain
| | - Olga Castañer
- Cardiovascular Risk and Nutrition Research Group, CIBER de Fisiopatología de la Obesidad y la Nutrición (CIBEROBN), IMIM-Institut Hospital del Mar d'Investigacions Mèdiques , C. Doctor Aiguader 88, 08003 Barcelona, Spain
| | - Rafael de la Torre
- Cardiovascular Risk and Nutrition Research Group, CIBER de Fisiopatología de la Obesidad y la Nutrición (CIBEROBN), IMIM-Institut Hospital del Mar d'Investigacions Mèdiques , C. Doctor Aiguader 88, 08003 Barcelona, Spain
| | - Rosa M Valls
- Unitat de Recerca en Lı́pids i Arteriosclerosis, CIBERDEM, St. Joan de Reus University Hospital, CTNS, IISPV, Facultat de Medicina i Ciències de la Salut, NFOC Group, Universitat Rovira i Virgili , C. Sant Llorenç 21, 43201 Reus, Spain
| | - Rosa Ras
- Center for Omics Sciences , Avenida Universitat 1, 43204 Reus, Spain
| | - Anna Pedret
- Unitat de Recerca en Lı́pids i Arteriosclerosis, CIBERDEM, St. Joan de Reus University Hospital, CTNS, IISPV, Facultat de Medicina i Ciències de la Salut, NFOC Group, Universitat Rovira i Virgili , C. Sant Llorenç 21, 43201 Reus, Spain
| | - Úrsula Catalán
- Unitat de Recerca en Lı́pids i Arteriosclerosis, CIBERDEM, St. Joan de Reus University Hospital, CTNS, IISPV, Facultat de Medicina i Ciències de la Salut, NFOC Group, Universitat Rovira i Virgili , C. Sant Llorenç 21, 43201 Reus, Spain
| | - María del Carmen López de las Hazas
- Food Technology Department, UTPV-XaRTA, Agrotecnio Research Center, Universitat de Lleida , C. Alcalde Rovira Roure 191, 25198 Lleida, Spain
| | - María J Motilva
- Food Technology Department, UTPV-XaRTA, Agrotecnio Research Center, Universitat de Lleida , C. Alcalde Rovira Roure 191, 25198 Lleida, Spain
| | - Montserrat Fitó
- Cardiovascular Risk and Nutrition Research Group, CIBER de Fisiopatología de la Obesidad y la Nutrición (CIBEROBN), IMIM-Institut Hospital del Mar d'Investigacions Mèdiques , C. Doctor Aiguader 88, 08003 Barcelona, Spain
| | - Rosa Solà
- Unitat de Recerca en Lı́pids i Arteriosclerosis, CIBERDEM, St. Joan de Reus University Hospital, CTNS, IISPV, Facultat de Medicina i Ciències de la Salut, NFOC Group, Universitat Rovira i Virgili , C. Sant Llorenç 21, 43201 Reus, Spain
| | - Montserrat Giralt
- Pharmacology Unit, Department of Basic Medical Sciences, Facultat de Medicina i Ciències de la Salut, NFOC group, Universitat Rovira i Virgili , C/Sant Llorenç 21, 43201 Reus, Spain
| |
Collapse
|
36
|
Martín-Peláez S, Mosele JI, Pizarro N, Farràs M, de la Torre R, Subirana I, Pérez-Cano FJ, Castañer O, Solà R, Fernandez-Castillejo S, Heredia S, Farré M, Motilva MJ, Fitó M. Effect of virgin olive oil and thyme phenolic compounds on blood lipid profile: implications of human gut microbiota. Eur J Nutr 2015; 56:119-131. [PMID: 26541328 DOI: 10.1007/s00394-015-1063-2] [Citation(s) in RCA: 88] [Impact Index Per Article: 8.8] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/27/2015] [Accepted: 09/25/2015] [Indexed: 01/21/2023]
Abstract
PURPOSE To investigate the effect of virgin olive oil phenolic compounds (PC) alone or in combination with thyme PC on blood lipid profile from hypercholesterolemic humans, and whether the changes generated are related with changes in gut microbiota populations and activities. METHODS A randomized, controlled, double-blind, crossover human trial (n = 12) was carried out. Participants ingested 25 mL/day for 3 weeks, preceded by 2-week washout periods, three raw virgin olive oils differing in the concentration and origin of PC: (1) a virgin olive oil (OO) naturally containing 80 mg PC/kg, (VOO), (2) a PC-enriched virgin olive oil containing 500 mg PC/kg, from OO (FVOO), and (3) a PC-enriched virgin olive oil containing a mixture of 500 mg PC/kg from OO and thyme, 1:1 (FVOOT). Blood lipid values and faecal quantitative changes in microbial populations, short chain fatty acids, cholesterol microbial metabolites, bile acids, and phenolic metabolites were analysed. RESULTS FVOOT decreased seric ox-LDL concentrations compared with pre-FVOOT, and increased numbers of bifidobacteria and the levels of the phenolic metabolite protocatechuic acid compared to VOO (P < 0.05). FVOO did not lead to changes in blood lipid profile nor quantitative changes in the microbial populations analysed, but increased the coprostanone compared to FVOOT (P < 0.05), and the levels of the faecal hydroxytyrosol and dihydroxyphenylacetic acids, compared with pre-intervention values and to VOO, respectively (P < 0.05). CONCLUSION The ingestion of a PC-enriched virgin olive oil, containing a mixture of olive oil and thyme PC for 3 weeks, decreases blood ox-LDL in hypercholesterolemic humans. This cardio-protective effect could be mediated by the increases in populations of bifidobacteria together with increases in PC microbial metabolites with antioxidant activities.
Collapse
Affiliation(s)
- Sandra Martín-Peláez
- Cardiovascular Risk and Nutrition Research Group, REGICOR Study Group, Hospital del Mar Research Institute (IMIM), Doctor Aiguader 88, 08003, Barcelona, Spain.
- Spanish Biomedical Research Networking Centre (CIBER), Physiopathology of Obesity and Nutrition (CIBERobn), Instituto de Salud Carlos III, Madrid, Spain.
| | - Juana Ines Mosele
- Food Technology Department, UTPV-XaRTA, Agrotecnio Research-Center, University of Lleida, Av. Alcalde Rovira Roure 191, 25198, Lleida, Spain
| | - Neus Pizarro
- Human Pharmacology and Clinical Neurosciences Research Group, IMIM, Doctor Aiguader 88, 08003, Barcelona, Spain
- Universidad Autónoma de Barcelona, Barcelona, Spain
| | - Marta Farràs
- Cardiovascular Risk and Nutrition Research Group, REGICOR Study Group, Hospital del Mar Research Institute (IMIM), Doctor Aiguader 88, 08003, Barcelona, Spain
- Spanish Biomedical Research Networking Centre (CIBER), Physiopathology of Obesity and Nutrition (CIBERobn), Instituto de Salud Carlos III, Madrid, Spain
- Universidad Autónoma de Barcelona, Barcelona, Spain
| | - Rafael de la Torre
- Spanish Biomedical Research Networking Centre (CIBER), Physiopathology of Obesity and Nutrition (CIBERobn), Instituto de Salud Carlos III, Madrid, Spain
- Human Pharmacology and Clinical Neurosciences Research Group, IMIM, Doctor Aiguader 88, 08003, Barcelona, Spain
- Universitat Pompeu Fabra, (CEXS-UPF), Barcelona, Spain
| | - Isaac Subirana
- Cardiovascular and Genetic Epidemiology Research Group, REGICOR Study Group, IMIM, Doctor Aiguader 88, 08003, Barcelona, Spain
- Spanish Biomedical Research Networking Centre (CIBER), Epidemiology and Public Health (CIBEResp), Instituto de Salud Carlos III, Madrid, Spain
| | - Francisco José Pérez-Cano
- Department of Physiology, Faculty of Pharmacy, Institute for Research on Nutrition and Food Safety (INSA-UB), B building, Joan XXIII, 27-30, 08028, Barcelona, Spain
| | - Olga Castañer
- Cardiovascular Risk and Nutrition Research Group, REGICOR Study Group, Hospital del Mar Research Institute (IMIM), Doctor Aiguader 88, 08003, Barcelona, Spain
- Spanish Biomedical Research Networking Centre (CIBER), Physiopathology of Obesity and Nutrition (CIBERobn), Instituto de Salud Carlos III, Madrid, Spain
| | - Rosa Solà
- Unit of Farmacobiology, Facultat de Medicina i Ciències de la Salut, Universitat Rovira I Virgili, Sant Llorenç 21, 43201, Reus, Spain
| | - Sara Fernandez-Castillejo
- Unit of Farmacobiology, Facultat de Medicina i Ciències de la Salut, Universitat Rovira I Virgili, Sant Llorenç 21, 43201, Reus, Spain
| | - Saray Heredia
- Cardiovascular Risk and Nutrition Research Group, REGICOR Study Group, Hospital del Mar Research Institute (IMIM), Doctor Aiguader 88, 08003, Barcelona, Spain
| | - Magí Farré
- Human Pharmacology and Clinical Neurosciences Research Group, IMIM, Doctor Aiguader 88, 08003, Barcelona, Spain
- Universitat Pompeu Fabra, (CEXS-UPF), Barcelona, Spain
| | - María José Motilva
- Food Technology Department, UTPV-XaRTA, Agrotecnio Research-Center, University of Lleida, Av. Alcalde Rovira Roure 191, 25198, Lleida, Spain
| | - Montserrat Fitó
- Cardiovascular Risk and Nutrition Research Group, REGICOR Study Group, Hospital del Mar Research Institute (IMIM), Doctor Aiguader 88, 08003, Barcelona, Spain.
- Spanish Biomedical Research Networking Centre (CIBER), Physiopathology of Obesity and Nutrition (CIBERobn), Instituto de Salud Carlos III, Madrid, Spain.
| |
Collapse
|
37
|
Gomes VPM, Torres C, Rodríguez-Borges JE, Paiva-Martins F. A Convenient Synthesis of Hydroxytyrosol Monosulfate Metabolites. JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY 2015; 63:9565-9571. [PMID: 26492463 DOI: 10.1021/acs.jafc.5b04307] [Citation(s) in RCA: 18] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/05/2023]
Abstract
The growing interest in the bioactivity of natural polyphenols and of their metabolites requires metabolites to be used in bioassays and as standards in research protocols. We report here on the synthesis of several hydroxytyrosol metabolite monosulfates achieved using a simplified protocol with improved yields. A synthetic solution based on avoidance of high temperature conditions during the synthesis and of low pressure conditions during purification has been established. Monosulfates of several phenolic compounds, namely, hydroxytyrosol, hydroxytyrosol acetate, homovanillyl alcohol, homovanillyl alcohol acetate, homovanillic acid, ferulic acid, and 3,4-dihydroxyphenylethanoic acid, were efficiently synthesized in 1-2 steps in good yield and isolated using simple procedures. The proposed protocol was shown to be relatively rapid, efficient, cheap, and widely applicable to a number of catechol scaffolds.
Collapse
Affiliation(s)
| | - Carmen Torres
- REQUIMTE, Faculdade de Ciências, Universidade do Porto , Rua do Campo Alegre, 687, 4169-007 Porto, Portugal
| | | | - Fátima Paiva-Martins
- REQUIMTE, Faculdade de Ciências, Universidade do Porto , Rua do Campo Alegre, 687, 4169-007 Porto, Portugal
| |
Collapse
|
38
|
Pérez-Jiménez J, Díaz-Rubio ME, Saura-Calixto F. Obtainment and characterization of a potential functional ingredient from olive. Int J Food Sci Nutr 2015; 66:749-54. [DOI: 10.3109/09637486.2015.1095863] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/11/2023]
|
39
|
Domínguez-Perles R, Auñón D, Ferreres F, Gil-Izquierdo A. Gender differences in plasma and urine metabolites from Sprague–Dawley rats after oral administration of normal and high doses of hydroxytyrosol, hydroxytyrosol acetate, and DOPAC. Eur J Nutr 2015; 56:215-224. [DOI: 10.1007/s00394-015-1071-2] [Citation(s) in RCA: 26] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/26/2015] [Accepted: 10/05/2015] [Indexed: 11/28/2022]
|
40
|
Catalán Ú, López de las Hazas MC, Rubió L, Fernández-Castillejo S, Pedret A, de la Torre R, Motilva MJ, Solà R. Protective effect of hydroxytyrosol and its predominant plasmatic human metabolites against endothelial dysfunction in human aortic endothelial cells. Mol Nutr Food Res 2015; 59:2523-36. [DOI: 10.1002/mnfr.201500361] [Citation(s) in RCA: 53] [Impact Index Per Article: 5.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/08/2015] [Revised: 09/03/2015] [Accepted: 09/10/2015] [Indexed: 12/15/2022]
Affiliation(s)
- Úrsula Catalán
- Functional Nutrition; Oxidation and Cardiovascular Diseases Group (NFOC-Salut); Unit of Lipids and Atherosclerosis Research (URLA); Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM); Hospital Universitari Sant Joan; IISPV; Technological Center of Nutrition and Health (CTNS); Faculty of Medicine and Health Sciences; Universitat Rovira i Virgili; Reus Spain
| | | | - Laura Rubió
- Functional Nutrition; Oxidation and Cardiovascular Diseases Group (NFOC-Salut); Unit of Lipids and Atherosclerosis Research (URLA); Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM); Hospital Universitari Sant Joan; IISPV; Technological Center of Nutrition and Health (CTNS); Faculty of Medicine and Health Sciences; Universitat Rovira i Virgili; Reus Spain
- Food Technology Department; Universitat de Lleida-AGROTECNIO Center; Lleida Lleida Spain
| | - Sara Fernández-Castillejo
- Functional Nutrition; Oxidation and Cardiovascular Diseases Group (NFOC-Salut); Unit of Lipids and Atherosclerosis Research (URLA); Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM); Hospital Universitari Sant Joan; IISPV; Technological Center of Nutrition and Health (CTNS); Faculty of Medicine and Health Sciences; Universitat Rovira i Virgili; Reus Spain
| | - Anna Pedret
- Functional Nutrition; Oxidation and Cardiovascular Diseases Group (NFOC-Salut); Unit of Lipids and Atherosclerosis Research (URLA); Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM); Hospital Universitari Sant Joan; IISPV; Technological Center of Nutrition and Health (CTNS); Faculty of Medicine and Health Sciences; Universitat Rovira i Virgili; Reus Spain
| | - Rafael de la Torre
- Centro de Investigación Biomédica en Red de Fisiopatología de la Obesidad y la Nutrición (CIBEROBN); Facultat de Ciencies de la Salut i de la Vida; Universitat Pompeu Fabra (CEXS-UPF); Institut Hospital del Mar d'Investigacions Mediques (IMIM); Barcelona Spain
| | - Maria-José Motilva
- Food Technology Department; Universitat de Lleida-AGROTECNIO Center; Lleida Lleida Spain
| | - Rosa Solà
- Functional Nutrition; Oxidation and Cardiovascular Diseases Group (NFOC-Salut); Unit of Lipids and Atherosclerosis Research (URLA); Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM); Hospital Universitari Sant Joan; IISPV; Technological Center of Nutrition and Health (CTNS); Faculty of Medicine and Health Sciences; Universitat Rovira i Virgili; Reus Spain
| |
Collapse
|
41
|
Mosele JI, Gosalbes MJ, Macià A, Rubió L, Vázquez-Castellanos JF, Jiménez Hernández N, Moya A, Latorre A, Motilva MJ. Effect of daily intake of pomegranate juice on fecal microbiota and feces metabolites from healthy volunteers. Mol Nutr Food Res 2015; 59:1942-1953. [PMID: 26228065 DOI: 10.1002/mnfr.201500227] [Citation(s) in RCA: 59] [Impact Index Per Article: 5.9] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/24/2015] [Revised: 07/15/2015] [Accepted: 07/16/2015] [Indexed: 02/05/2023]
Abstract
SCOPE The purpose of the study was to evaluate the effect, regarding the metabolic and microbial profile of feces, of diet supplementation of healthy adults with pomegranate juice (PJ). METHODS AND RESULTS Twelve healthy adults were recruited to the study, which consisted of the intake of 200 mL/day of PJ during 4 weeks. Feces were collected before and after the supplementation with PJ. Metabolites (phenolic catabolites, short-chain fatty acids, and fecal steroids) and microbial profile were analyzed at baseline and at 4 weeks. Fecal phenolic metabolites, 3-phenylpropionic acid, catechol, hydroxytyrosol, and urolithin A, showed a significant increase in their concentration after supplementation with PJ. Among fecal steroids, parallel to the significant increase of cholesterol concentration, a significant decrease of coprostanol was observed. Although no significant changes in the microbiota profile were observed, different relationships between initial microbiota and the metabolites produced were found. Catechol showed positive and negative correlation with Oscillospora and Paraprevotella genera, respectively, and 3-phenylpropionic acid was positively correlated with Odoribacter genus. CONCLUSION Inclusion of PJ in the diet did not significantly alter the gut microbiota composition in healthy adults, but the individual bacterial composition could contribute to the generation of potential health-promoting phenolic metabolites.
Collapse
Affiliation(s)
- Juana I Mosele
- Food Technology Department, Agrotecnio Center, University of Lleida, Lleida, Spain
| | - María-José Gosalbes
- Unidad Mixta de Investigación en Genómica y Salud de la Fundación para el Fomento de la Investigación Sanitaria y Biomédica (FISABIO-Salud Pública) y del Instituto Cavanilles de Biodiversidad y Biología Evolutiva (Universitat de València), València, Spain
- CIBERESP (Consorcio de Investigación Biomédica de Epidemiología y Salud Pública), Madrid, Spain
| | - Alba Macià
- Food Technology Department, Agrotecnio Center, University of Lleida, Lleida, Spain
| | - Laura Rubió
- Functional Nutrition, Oxidation and Cardiovascular Diseases Group (NFOC-Salut), Unit of Lipids and Atherosclerosis Research (URLA), Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Hospital Universitari Sant Joan, IISPV, Technological Center of Nutrition and Health (CTNS), Faculty of Medicine and Health Sciences, Universitat Rovira i Virgili, Reus, Spain
| | - Jorge F Vázquez-Castellanos
- Unidad Mixta de Investigación en Genómica y Salud de la Fundación para el Fomento de la Investigación Sanitaria y Biomédica (FISABIO-Salud Pública) y del Instituto Cavanilles de Biodiversidad y Biología Evolutiva (Universitat de València), València, Spain
- CIBERESP (Consorcio de Investigación Biomédica de Epidemiología y Salud Pública), Madrid, Spain
| | - Nuria Jiménez Hernández
- Unidad Mixta de Investigación en Genómica y Salud de la Fundación para el Fomento de la Investigación Sanitaria y Biomédica (FISABIO-Salud Pública) y del Instituto Cavanilles de Biodiversidad y Biología Evolutiva (Universitat de València), València, Spain
- CIBERESP (Consorcio de Investigación Biomédica de Epidemiología y Salud Pública), Madrid, Spain
| | - Andrés Moya
- Unidad Mixta de Investigación en Genómica y Salud de la Fundación para el Fomento de la Investigación Sanitaria y Biomédica (FISABIO-Salud Pública) y del Instituto Cavanilles de Biodiversidad y Biología Evolutiva (Universitat de València), València, Spain
- CIBERESP (Consorcio de Investigación Biomédica de Epidemiología y Salud Pública), Madrid, Spain
| | - Amparo Latorre
- Unidad Mixta de Investigación en Genómica y Salud de la Fundación para el Fomento de la Investigación Sanitaria y Biomédica (FISABIO-Salud Pública) y del Instituto Cavanilles de Biodiversidad y Biología Evolutiva (Universitat de València), València, Spain
- CIBERESP (Consorcio de Investigación Biomédica de Epidemiología y Salud Pública), Madrid, Spain
| | - María-José Motilva
- Food Technology Department, Agrotecnio Center, University of Lleida, Lleida, Spain
| |
Collapse
|
42
|
Motilva MJ, Serra A, Rubió L. Nutrikinetic studies of food bioactive compounds: fromin vitrotoin vivoapproaches. Int J Food Sci Nutr 2015; 66 Suppl 1:S41-52. [DOI: 10.3109/09637486.2015.1025721] [Citation(s) in RCA: 20] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/17/2022]
|
43
|
Farràs M, Castañer O, Martín-Peláez S, Hernáez Á, Schröder H, Subirana I, Muñoz-Aguayo D, Gaixas S, Torre RDL, Farré M, Rubió L, Díaz Ó, Fernández-Castillejo S, Solà R, Motilva MJ, Fitó M. Complementary phenol-enriched olive oil improves HDL characteristics in hypercholesterolemic subjects. A randomized, double-blind, crossover, controlled trial. The VOHF study. Mol Nutr Food Res 2015; 59:1758-70. [DOI: 10.1002/mnfr.201500030] [Citation(s) in RCA: 36] [Impact Index Per Article: 3.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/15/2015] [Revised: 03/31/2015] [Accepted: 05/06/2015] [Indexed: 12/19/2022]
Affiliation(s)
- Marta Farràs
- Cardiovascular Risk and Nutrition Research Group; Regicor Study Group, IMIM (Hospital del Mar Medical Research Institute); Barcelona Spain
- CIBER de Fisiopatología de la Obesidad y la Nutrición (CIBEROBN); Instituto de Salud Carlos III; Madrid Spain
- Ph.D. Program in Biochemistry; Molecular Biology and Biomedicine; Department of Biochemistry and Molecular Biology; Universitat Autònoma de Barcelona (UAB); Barcelona Spain
| | - Olga Castañer
- Cardiovascular Risk and Nutrition Research Group; Regicor Study Group, IMIM (Hospital del Mar Medical Research Institute); Barcelona Spain
- CIBER de Fisiopatología de la Obesidad y la Nutrición (CIBEROBN); Instituto de Salud Carlos III; Madrid Spain
| | - Sandra Martín-Peláez
- Cardiovascular Risk and Nutrition Research Group; Regicor Study Group, IMIM (Hospital del Mar Medical Research Institute); Barcelona Spain
| | - Álvaro Hernáez
- Cardiovascular Risk and Nutrition Research Group; Regicor Study Group, IMIM (Hospital del Mar Medical Research Institute); Barcelona Spain
| | - Helmut Schröder
- Cardiovascular Risk and Nutrition Research Group; Regicor Study Group, IMIM (Hospital del Mar Medical Research Institute); Barcelona Spain
- CIBER de Epidemiología y Salud Pública (CIBERESP); Instituto de Salud Carlos III; Madrid Spain
| | - Isaac Subirana
- CIBER de Epidemiología y Salud Pública (CIBERESP); Instituto de Salud Carlos III; Madrid Spain
- Cardiovascular Epidemiology and Genetics Research Group; Regicor Study Group, IMIM (Hospital del Mar Medical Research Institute); Barcelona Spain
| | - Daniel Muñoz-Aguayo
- Cardiovascular Risk and Nutrition Research Group; Regicor Study Group, IMIM (Hospital del Mar Medical Research Institute); Barcelona Spain
| | - Sònia Gaixas
- Cardiovascular Epidemiology and Genetics Research Group; Regicor Study Group, IMIM (Hospital del Mar Medical Research Institute); Barcelona Spain
| | - Rafael de la Torre
- CIBER de Fisiopatología de la Obesidad y la Nutrición (CIBEROBN); Instituto de Salud Carlos III; Madrid Spain
- Human Pharmacology and Clinical Neurosciences Research Group; IMIM (Hospital del Mar Medical Research Institute); Barcelona Spain
- Universitat Pompeu Fabra (CEXS-UPF); Barcelona Spain
| | - Magí Farré
- Human Pharmacology and Clinical Neurosciences Research Group; IMIM (Hospital del Mar Medical Research Institute); Barcelona Spain
- Universitat Autònoma de Barcelona (UAB); Barcelona Spain
| | - Laura Rubió
- Food Technology Department; UTPV-XaRTA; Agrotecnio Center; University of Lleida; Lleida Spain
| | - Óscar Díaz
- Cardiovascular Risk and Nutrition Research Group; Regicor Study Group, IMIM (Hospital del Mar Medical Research Institute); Barcelona Spain
| | - Sara Fernández-Castillejo
- Unitat de Recerca en Lípids i Arteriosclerosis; CIBERDEM, St. Joan de Reus University Hospital; IISPV; Facultat de Medicina i Ciències de la Salut; Universitat Rovira i Virgili; Reus Spain
| | - Rosa Solà
- Unitat de Recerca en Lípids i Arteriosclerosis; CIBERDEM, St. Joan de Reus University Hospital; IISPV; Facultat de Medicina i Ciències de la Salut; Universitat Rovira i Virgili; Reus Spain
| | - Maria José Motilva
- Food Technology Department; UTPV-XaRTA; Agrotecnio Center; University of Lleida; Lleida Spain
| | - Montserrat Fitó
- Cardiovascular Risk and Nutrition Research Group; Regicor Study Group, IMIM (Hospital del Mar Medical Research Institute); Barcelona Spain
- CIBER de Fisiopatología de la Obesidad y la Nutrición (CIBEROBN); Instituto de Salud Carlos III; Madrid Spain
| |
Collapse
|
44
|
Pedret A, Catalán Ú, Fernández-Castillejo S, Farràs M, Valls RM, Rubió L, Canela N, Aragonés G, Romeu M, Castañer O, de la Torre R, Covas MI, Fitó M, Motilva MJ, Solà R. Impact of Virgin Olive Oil and Phenol-Enriched Virgin Olive Oils on the HDL Proteome in Hypercholesterolemic Subjects: A Double Blind, Randomized, Controlled, Cross-Over Clinical Trial (VOHF Study). PLoS One 2015; 10:e0129160. [PMID: 26061039 PMCID: PMC4465699 DOI: 10.1371/journal.pone.0129160] [Citation(s) in RCA: 36] [Impact Index Per Article: 3.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/18/2014] [Accepted: 05/03/2015] [Indexed: 12/21/2022] Open
Abstract
UNLABELLED The effects of olive oil phenolic compounds (PCs) on HDL proteome, with respect to new aspects of cardioprotective properties, are still unknown. The aim of this study was to assess the impact on the HDL protein cargo of the intake of virgin olive oil (VOO) and two functional VOOs, enriched with their own PCs (FVOO) or complemented with thyme PCs (FVOOT), in hypercholesterolemic subjects. Eligible volunteers were recruited from the IMIM-Hospital del Mar Medical Research Institute (Spain) from April 2012 to September 2012. Thirty-three hypercholesterolemic participants (total cholesterol >200 mg/dL; 19 men and 14 women; aged 35 to 80 years) were randomized in the double-blind, controlled, cross-over VOHF clinical trial. The subjects received for 3 weeks 25 mL/day of: VOO, FVOO, or FVOOT. Using a quantitative proteomics approach, 127 HDL-associated proteins were identified. Among these, 15 were commonly differently expressed after the three VOO interventions compared to baseline, with specific changes observed for each intervention. The 15 common proteins were mainly involved in the following pathways: LXR/RXR activation, acute phase response, and atherosclerosis. The three VOOs were well tolerated by all participants. Consumption of VOO, or phenol-enriched VOOs, has an impact on the HDL proteome in a cardioprotective mode by up-regulating proteins related to cholesterol homeostasis, protection against oxidation and blood coagulation while down-regulating proteins implicated in acute-phase response, lipid transport, and immune response. The common observed protein expression modifications after the three VOOs indicate a major matrix effect. TRIAL REGISTRATION International Standard Randomized Controlled Trials ISRCTN77500181.
Collapse
Affiliation(s)
- Anna Pedret
- Research Unit on Lipids and Atherosclerosis, CTNS, CIBERDEM, Hospital Universitari Sant Joan, Servei de Medicina Interna, IISPV, Universitat Rovira i Virgili, Reus, Spain
| | - Úrsula Catalán
- Research Unit on Lipids and Atherosclerosis, CTNS, CIBERDEM, Hospital Universitari Sant Joan, Servei de Medicina Interna, IISPV, Universitat Rovira i Virgili, Reus, Spain
| | - Sara Fernández-Castillejo
- Research Unit on Lipids and Atherosclerosis, CTNS, CIBERDEM, Hospital Universitari Sant Joan, Servei de Medicina Interna, IISPV, Universitat Rovira i Virgili, Reus, Spain
| | - Marta Farràs
- Cardiovascular Risk and Nutrition Research Group (CARIN, Regicor Study Group), CIBER de Fisiopatología de la Obesidad y la Nutrición (CIBEROBN), IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain
- Ph.D. Program in Biochemistry, Molecular Biology and Biomedicine, Department of Biochemistry and Molecular Biology, Universitat Autònoma de Barcelona (UAB), Barcelona, Spain
| | - Rosa-M Valls
- Research Unit on Lipids and Atherosclerosis, CTNS, CIBERDEM, Hospital Universitari Sant Joan, Servei de Medicina Interna, IISPV, Universitat Rovira i Virgili, Reus, Spain
| | - Laura Rubió
- Research Unit on Lipids and Atherosclerosis, CTNS, CIBERDEM, Hospital Universitari Sant Joan, Servei de Medicina Interna, IISPV, Universitat Rovira i Virgili, Reus, Spain
- Food Technology Department, UTPV-XaRTA, University of Lleida-AGROTECNIO Research Centre, Lleida, Spain
| | - Núria Canela
- Centre for Omic Sciences (COS), Universitat Rovira i Virgili, Reus, Spain
| | - Gerard Aragonés
- Centre for Omic Sciences (COS), Universitat Rovira i Virgili, Reus, Spain
| | - Marta Romeu
- Pharmacology Unit, Facultat de Medicina i Ciències de la Salut, Universitat Rovira i Virgili, Reus, Spain
| | - Olga Castañer
- Cardiovascular Risk and Nutrition Research Group (CARIN, Regicor Study Group), CIBER de Fisiopatología de la Obesidad y la Nutrición (CIBEROBN), IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain
| | - Rafael de la Torre
- Human Pharmacology and Clinical Neurosciences Research Group, CIBER de Fisiopatología de la Obesidad y la Nutrición (CIBEROBN), IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain
- Universitat Pompeu Fabra (CEXS-UPF), Barcelona, Spain
| | - Maria-Isabel Covas
- Cardiovascular Risk and Nutrition Research Group (CARIN, Regicor Study Group), CIBER de Fisiopatología de la Obesidad y la Nutrición (CIBEROBN), IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain
| | - Montse Fitó
- Cardiovascular Risk and Nutrition Research Group (CARIN, Regicor Study Group), CIBER de Fisiopatología de la Obesidad y la Nutrición (CIBEROBN), IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain
| | - Maria-José Motilva
- Food Technology Department, UTPV-XaRTA, University of Lleida-AGROTECNIO Research Centre, Lleida, Spain
| | - Rosa Solà
- Research Unit on Lipids and Atherosclerosis, CTNS, CIBERDEM, Hospital Universitari Sant Joan, Servei de Medicina Interna, IISPV, Universitat Rovira i Virgili, Reus, Spain
| |
Collapse
|
45
|
Giordano E, Dangles O, Rakotomanomana N, Baracchini S, Visioli F. 3-O-Hydroxytyrosol glucuronide and 4-O-hydroxytyrosol glucuronide reduce endoplasmic reticulum stress in vitro. Food Funct 2015; 6:3275-81. [DOI: 10.1039/c5fo00562k] [Citation(s) in RCA: 27] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/16/2022]
Abstract
Endoplasmic reticulum (ER) stress is important for atherosclerosis development and is mediated by the unfolded protein response (UPR).
Collapse
Affiliation(s)
- Elena Giordano
- Laboratory of Functional Foods
- Madrid Institute for Advanced Studies (IMDEA) – Food
- UAM+CSIC
- Madrid
- Spain
| | | | | | - Silvia Baracchini
- Laboratory of Functional Foods
- Madrid Institute for Advanced Studies (IMDEA) – Food
- UAM+CSIC
- Madrid
- Spain
| | - Francesco Visioli
- Laboratory of Functional Foods
- Madrid Institute for Advanced Studies (IMDEA) – Food
- UAM+CSIC
- Madrid
- Spain
| |
Collapse
|
46
|
Mosele JI, Martín-Peláez S, Macià A, Farràs M, Valls RM, Catalán Ú, Motilva MJ. Study of the catabolism of thyme phenols combining in vitro fermentation and human intervention. JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY 2014; 62:10954-10961. [PMID: 25339317 DOI: 10.1021/jf503748y] [Citation(s) in RCA: 29] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/04/2023]
Abstract
The gut metabolism of four thyme phenolics (monoterpenes thymol and carvacrol, rosmarinic acid, and eriodictyol) was evaluated in vitro. After the in vitro transformations of the individual phenols had been studied, the presence of their microbial metabolites was investigated in human feces collected before and after a sustained intake (3 weeks) of 25 mL/day of a thyme phenol-enriched olive oil. Results of in vitro fermentation showed low degradation of thymol and carvacrol. By contrast, large catabolism was noted when rosmarinic acid and eriodictyol were fermented, yielding hydroxyphenylpropionic acid as the main metabolite. In accordance with these results, after the in vivo intervention with thyme phenol-enriched olive oil, an increase in the concentration of hydroxyphenylpropionic and phenylpropionic acids was observed in human feces, confirming the effective in vivo microbial degradation of rosmarinic acid and eriodictyol. Carvacrol was detected in fecal samples at trace levels, suggesting that monoterpenes are well absorbed in the upper part of the gastrointestinal tract.
Collapse
Affiliation(s)
- Juana I Mosele
- Food Technology Department, UTPV-XaRTA, Agrotecnio Research Center - University of Lleida , Av/Alcalde Rovira Roure 191, 25198 Lleida, Spain
| | | | | | | | | | | | | |
Collapse
|